Measuring Geospatial and Longitudinal Trends in Malaria Using National Health Surveillance Data in Malawi by Topazian, Hillary
 
MEASURING GEOSPATIAL AND LONGITUDINAL TRENDS IN MALARIA USING 
NATIONAL HEALTH SURVEILLANCE DATA IN MALAWI 
 
Hillary M. Topazian 
 
A dissertation submitted to the faculty at the University of North Carolina at Chapel Hill in 
partial fulfillment of the requirements for the degree of Doctor of Philosophy in the Department 





 Approved by: 
 Audrey Pettifor 
 Jessie K. Edwards 
 Michael Emch 
 Irving Hoffman  
 Jonathan J. Juliano 






























Hillary M. Topazian 






Hillary M. Topazian: Measuring Geospatial and Longitudinal Trends in Malaria Using National 
Health Surveillance Data in Malawi 
(Under the direction of Audrey Pettifor) 
 
  Malaria is a significant cause of morbidity and mortality in Malawi, accounting 
for 30% of outpatient visits. Children report the highest rates of disease, but adults are thought to 
be an important reservoir to sustained transmission due to persistent asymptomatic infection. 
However, national malaria measures have been exclusively estimated through Malaria Indicator 
Surveys which only offer a regional cross-sectional glance at parasite prevalence among 
children. Malaria is geographically and temporally heterogeneous, making it necessary to 
understand local and longitudinal transmission patterns before planning targeted interventions. 
Long-lasting insecticide treated bed nets (LLINs) are integral to Malawi’s malaria prevention 
efforts and are allocated to households every 3-years through mass distribution campaigns. 
Evidence suggests that the maximum protective lifespan of LLINs is 1-3-years, but a national 
longitudinal evaluation has never been conducted in Malawi. 
 The 2015-2016 Malawi Demographic and Health Survey (MDHS) was a nationally 
representative household survey of asymptomatic individuals ages 15-54. We analyzed 7,393 
survey samples, detecting a P. falciparum prevalence of 31.1%. Protective factors included 
urbanicity, greater wealth, higher education, and lower environmental temperatures, but living in 
a household with a bed net and sleeping under an LLIN were not protective against infection.  
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 To assess clinical malaria over time, we used District Health Information Software 2 
(DHIS2) data from January 2018 to June 2020, capturing monthly aggregate reports of 
confirmed cases from 711 health facilities across Malawi. We found that risk varied at the health 
facility level and was highest from January to May. Risk decreased one high transmission season 
following distribution of 10.7 million LLINs and rebounded after two seasons, indicating that 
LLINs only have a lifespan of 1-2-years. Piperonyl butoxide-treated nets performed better than 
pyrethroid-treated nets and LLIN effectiveness varied geographically. 
 Our findings demonstrate a high parasite prevalence among adults, highlighting this 
population as an important reservoir to sustained transmission. LLINs have a 1-2-year lifespan 
and insecticide type influences effectiveness. Use of molecular surveillance to supplement 
ongoing passive data collection creates a natural opportunity to track how large-scale changes 
affect malaria over time and provide valuable insight to the Malawi Ministry of Health as they 
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CHAPTER ONE: SPECIFIC AIMS 
There were an estimated 7.0 million malaria cases in Malawi in 2018.1 Malaria remains 
an important cause of childhood morbidity and mortality, with an estimated annual Plasmodium. 
falciparum parasite rate of 18-19% in children 2-10 years in 2015-2016.2 While children report 
the highest proportions of clinical disease,3 adults are thought to be an important reservoir to 
sustained transmission due to persistent asymptomatic infections with low parasite densities 
undetectable by microscopy or rapid diagnostic test.4 Malaria is also geographically and 
temporally heterogenous, and risk in Malawi has been found to be modified by several 
environmental risk factors including altitude, rainfall, temperature, potential evapotranspiration, 
and proximity to active agriculture.5–7 Little is known about the prevalence of adult 
asymptomatic malaria infections, and if risk factors are similar to those among children. 
Recent estimates of the malaria burden in Malawi have come from cross-sectional 
Malaria Indicator Surveys in 2012, 2014, and 2017. While these surveys randomly sampled 
households at a granular scale, they only offer estimates of malaria prevalence and preventative 
behaviors among children in broad geographic locations, and at specific points in time. Malawi 
has established a passive system, the District Health Information Software 2 (DHIS2), which 
provides monthly malaria statistics from health facilities in a cost-effective and timely manner, 
but no analysis has utilized DHIS2 to calculate malaria risk at a sub-district level. Long-lasting 
insecticide-treated nets (LLINs) are Malawi’s predominant vector control strategy,8 with bed nets 
given to all pregnant women, newborn babies, and to the general population every three years 
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through mass distribution campaigns.9 However, there has been no national longitudinal study of 
the effects of mass distribution campaigns on long-term malaria risk. 
The objective of the proposed analysis is to identify risk factors for the prevalence of 
asymptomatic P. falciparum among adolescents and adults ages 15-54, and to longitudinally 
assess the effectiveness of an LLIN mass distribution campaign on the monthly risk of confirmed 
malaria at the health facility level.  
The specific aims of this proposal are to: 
1. Identify variations in the prevalence of asymptomatic PCR-positive P. falciparum, due 
to demographic, environmental, and spatial risk factors in adolescent and adults ages 
15-54. Using dried blood spots collected from the Malawi Demographic and Health Survey 
2015-2016 (MDHS), we will conduct quantitative PCR to detect parasitemia. We will 
identify risk factors for infection taken from the MDHS and environmental data sources.  
Hypothesis: individuals using bed nets treated with non-permethrin insecticides will have a 
lower infection prevalence than individuals using permethrin-treated nets. Risk factors will 
be consistent with those observed in asymptomatic children and symptomatic children and 
adults.  
2. Assess differences in the monthly risk of confirmed malaria across health facilities in 
Malawi from 2018-2020, before and after a mass distribution campaign at the end of 
2018. Using existing DHIS2 health facility surveillance data, we will compare population 
risk across Malawi by month. We will stratify estimates between children <5 and persons 
≥5 years, and by LLIN insecticide type or application of indoor residual spraying. All 
malaria cases presenting to clinics are captured in DHIS2 and the population denominator 
will be estimated from WorldPop geospatial data.10  
3 
Hypothesis: areas receiving piperonyl butoxide-treated nets will experience a greater 
reduction in malaria risk estimates as compared to areas receiving pyrethroid-treated nets, 
after the LLIN mass distribution campaign from September to December 2018.  
Understanding the prevalence and spatial distribution of the asymptomatic malaria 
reservoir in Malawi is essential for implementation and evaluation of control measures. 
Molecular surveillance of P. falciparum in adults can be an important tool for the Malawi 
Ministry of Health (MOH) to supplement ongoing collection of clinical data through DHIS2 and 
periodic national surveys of prevalence among children. Assessment of risk measures will 
provide valuable insight into current and historical malaria case trends and advise the type and 
frequency of future LLIN mass distribution campaigns.   
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CHAPTER TWO: BACKGROUND AND INNOVATION 
Overview of Malaria 
Malaria is caused by infection with a parasite transmitted by female Anopheles 
mosquitoes.11 There are five species of malaria which infect humans: Plasmodium falciparum, P. 
vivax, P. ovale, P. malariae, and P. knowlesi. The malaria parasite is transmitted from the 
Anopheles mosquito to a human host through a blood meal; the parasite then multiplies in the 
liver and red blood cells, eventually forming a sexual stage which is taken up by another 
mosquito to continue the transmission cycle (Figure 2.1).  
 
Figure 2.1 Malaria parasite life cycle (adapted).12 
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Once infected, humans experience a 7-30 day incubation period before manifestation of 
clinical disease, characterized by fever, chills, sweats, headaches, nausea, and vomiting.11,13 
Cases of severe and cerebral malaria can lead to seizures, severe anemia, acute respiratory 
distress syndrome, and death. Infection with malaria throughout the life-course can generate a 
certain degree of immunity to clinical disease; as children grow up, parasites can cause sub-
clinical infection that remains untreated.13 Immunity exists against the presence of high parasite 
densities (anti-parasite) and against development of malarial disease symptoms (anti-disease), 
and the presence of immunity varies by age and the transmission intensity in the setting of 
interest (high/moderate/low).14 As a result, a reservoir exists among people asymptomatically 
infected with malaria, but whom are still able to transmit to others.15  
 Malaria is diagnosed through point-of-care rapid diagnostic tests (RDTs), microscopic 
examination looking for parasites in blood, or through nucleic acid amplification-based 
diagnostics such as polymerase-chain reaction (PCR)-based methods.13,16 RDTs detect parasite 
antigens in the blood and are used in outpatient settings to quickly diagnose malaria. RDTs can 
occasionally result in false-positive results from persistence of histidine-rich protein 2 (HRP-2) 
antigen after treatment or false-negative results caused by pfhrp2 gene deletions in some parasite 
strains.13,17 Microscopy makes use of a microscope to visually detect parasites in blood smears. 
PCR requires more advanced technical capacity but can be used to detect an infection with low 
parasitemia that may not be identified through RDT or microscopy.13,16  Diagnostic tests are 
important for providing quick results, but have limited lower limits of detection (microscopy: 50 
parasites/µL of blood18, RDT: 100-200 parasites/µL19,20). Microscopy is the standard testing 
procedure at hospitals, but can suffer from poor quality diagnosis; RDTs are particularly useful 
in remote areas and for quick management of malaria disease, and PCR is recommended in 
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research and survey settings due to the high sensitivity of molecular detection techniques.16 
Choice of diagnostic test can lead to drastically differing estimates of infection prevalence due to 
lower limits of detection; particularly among submicroscopic infections in low transmission 
areas.21 In malaria endemic regions, microscopy misses half of P. falciparum infections found by 
PCR,22 yest theses submicroscopic infections are likely to contribute to sustained transmission in 
areas where use of microscopy results low infection prevalences.21  
Global Burden of Malaria 
 There were 228 million malaria cases globally in 2018, primarily occurring in the World 
Health Organization’s (WHO) Africa (93%) and South-East Asia Regions (3.4%) (Figure 2.2).23 
An estimated 405,000 deaths from malaria occurred worldwide in 2018, with children under 5 
years representing 67% of all fatalities. The incidence rate of malaria has declined since 2010, 
although the rate of change has slowed in the last few years. WHO technical strategy goals for 
2030 include reducing malaria incidence by 90% and eliminating malaria in 35 countries.24 
 In sub-Saharan Africa, the number of cases decreased from 2010 to 2015, but has risen 
steadily each year from 2016-2018,23 indicating the need for increased malaria prevention 
implementation in the region and the development of new technologies. The number of malaria 
deaths has declined steadily since 2010 in sub-Saharan Africa. P. falciparum is the most 
common species in Africa, representing 99.7% of all infections.23  
 Funding for malaria control and elimination reached US$ 2.7 billion in 2018, 
representing key partnerships between endemic countries and the global community, with 70% 
coming from the international parnters.23 The majority, 37.8%, of malaria funding from 1997-
2013 came from public health research, with 33.8% from clinical trials.25 Malaria research 
represents an important part of monitoring malaria trends, determining the effectiveness of 
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interventions, developing new treatment and prevention strategies, and forming international 
partnerships. 
 
Figure 2.2 Global distribution of malaria.13 
 
Malaria Prevention Mechanisms 
 A plethora of interventions have been developed to reduce mosquito vector prevalence 
and to interrupt the transmission cycle from human to mosquito, including long-lasting 
insecticide treated bed nets (LLINs), indoor residual spraying (IRS), and chemoprevention. 
LLINs act as a physical barrier between humans and mosquito vectors, and as a chemical barrier, 
killing mosquitoes which land on the insecticide covering the net.26 Resistance to insecticides 
such as pyrethroids, carbamates, organochlorines, and organophosphates, are widespread 
globally,27 however an intact net treated with an ineffective insecticide can still provide benefit 
by acting as a physical obstacle. IRS involves spraying insecticide on the walls of a dwelling to 
kill mosquitoes which land on surfaces. Chemoprevention is also used to reduce seasonal malaria 
incidence and administered to children and pregnant women through intermittent preventive 
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treatment. Most recently, the RTS,S/AS01 vaccine has been developed to prevent malaria, but 
has shown mixed efficacy in sub-Saharan Africa by age group and geographic location in a 
Phase III trial.28 However, even with simultaneous mass scale-up of LLINs, IRS, and 
chemoprevention strategies to 90% coverage, the introduction of novel interventions will still be 
necessary to even begin to consider global malaria eradication.29  
Malaria in Malawi 
 Malaria is endemic in Malawi and the entire population is at risk of infection, particularly 
during annual high transmission seasons associated with greater rainfall.30,31 Malaria patterns are 
geographically and temporally heterogenous in Malawi. Infection rates are higher along the 
shores of Lake Malawi and in the Shire river valley, and lower in cooler high elevation areas.9 
Cases occur all year round, however, transmission is highest following the annual rainy season, 
with elevated numbers of cases in January through May.9 At present, national level clinical 
malaria data have only been released at the district and national levels, recording 7.0 million 
confirmed cases in 2018.32 Malaria cases make up 30% of outpatient visits and 34% of inpatient 
hospital stays in Malawi,9 placing a substantial burden of disease on the health care system.  
 Globally, malaria risk has been found to be modified by several environmental factors, 
including temperature, precipitation, water pooling, elevation, deforestation, agriculture, and 
others.33 In Malawi some of these factors include altitude, rainfall, temperature, potential 
evapotranspiration, and proximity to active agriculture.5–7 In Lilongwe, malaria incidence curves 
among children have been found to closely mimic curves of monthly rainfall, with highest 
malaria incidence estimates occurring shortly after the months of greatest rainfall (Figure 2.3).34  
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Figure 2.3 Malaria incidence and rainfall patterns, 2009-2014, Lilongwe, Malawi.34 
 
 Most research on malaria prevalence focuses on P. falciparum prevalence among 
children, an age group particularly at risk for malaria morbidity and death.3 In 2017, prevalence 
by microscopy was 26% in the Central and Southern regions and 11% in the Northern region 
during the high malaria transmission season.35 Employing models of survey data utilizing 
microscopy and RDT, the annual P. falciparum parasite rate was estimated to be 18-19% in 
children ages 2-10 years in Malawi in 2015-2016,2 however there have been no national 
estimates of malaria prevalence among adults. 
 Insecticide-treated bed nets (ITNs) are Malawi’s predominant vector control strategy,8 
with bed nets given to all pregnant women, newborn babies, and to the general population 
periodically through mass distribution campaigns. IRS is administered yearly in two districts, 
with plans for future expansion.32 In addition, entomological monitoring takes place in targeted 
locations, and ITN durability monitoring occurs annually.  
 Prior research studying universal bed net distribution has shown short-term signs of 
benefit from ITN campaigns, but a lack of sustained effectiveness. One study demonstrated 
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decreasing estimates of parasite infection and clinical malaria among pregnant women after a 
mass distribution campaign in 2012, however prevalence began increasing two years following 
the campaign.36 Increased malaria prevalence also occurred among children two years after mass 
distribution of 5.6 million nets, despite reporting increased bed net usage over the same time 
period.37 Individual ITN use was associated with a lower individual risk of malaria at baseline, 
but this association disappeared within two years. Similarly, research among adolescents and 
adults has shown that sleeping under an LLIN was not associated with reduced risk of malaria 
prevalence 3-4 years after a mass distribution campaign, even after stratifying by bed net 
insecticide type.38 Among school-aged children in Malawi, ITN use increased immediately 
following a local universal distribution campaign, but usage decreased back to baseline within 3 
years, indicating that a universal ITN campaign combined with routine distribution is not 
sufficient for long term changes in net use.39 In Malawi, individuals repurpose ITNs for fishing 
and farming, and sell nets to support their families encountering poverty and food-insecurity,40 
all of which contribute to reduced intervention effectiveness. Older ITNs are also associated with 
higher infection prevalence, despite the lack of association between net integrity and infection, 
suggesting that reduced insecticide concentrations over time also hinder effectiveness.41 
 Malawi is also beginning to evaluate programmatic use of RTS,S/AS01, a vaccine 
developed to reduce incidence of malaria among children in sub-Saharan Africa.28 Malaria is an 
incredibly complex parasite, with over 5,000 genes and hundreds of potential targets across the 
Plasmodium life cycle, many of which have been and are currently being explored for vaccine 
development.12 RTS,S/AS01 is constructed using the circumsporozoite protein C-terminal as the 
target antigen to generate a host response to parasite sporozoites in the bloodstream and dormant 
forms in the liver, prior to the host experiencing symptoms of disease.42,43 Most recently, a 
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randomized Phase III trial of RTS,S/AS01 across 11 sites in sub-Saharan Africa from 2009-
2013, estimated a study-wide vaccine efficacy of 36.3% (95% CI: 31.8 to 40.5) against clinical 
malaria in children 5-17 months of age, and 25.9% (95% CI: 19.9 to 31.5) in infants 6-12 
weeks.28 However, efficacy varied widely depending on geographic site. In Lilongwe, Malawi, 
point estimates of vaccine efficacy were higher than the trial’s composite results, at 50.8% (95% 
CI: 31.4 to 64.7) in children 5-17 months and 38.9% (95% CI: 16.8 to 55.1) in infants 6-12 
weeks. The best efficacy estimates were achieved with four doses of the vaccine. Programatic 
implementation of RTS,S/AS01 in Malawi began in April 2019 and will continue through 2024, 
with clusters of health facilities randomized to receive or to not receive the vaccine through the 
Malaria Vaccine Implementation Program evaluation, a partnership between the World Health 
Organization, the Malawi Ministry of Health, the University of North Carolina, and the Malawi 
College of Medicine. 
 The Malawi Ministry of Health has drafted specific goals to reduce malaria incidence and 
malaria-related deaths in the coming years. Malawi’s Health Sector Strategic Plan aims to cut the 
malaria incidence rate of presumed and confirmed cases from 2015 levels of 380 per 1,000 to 
200 per 1,000 by 2021.44 The same plan also hopes to cut inpatient malaria deaths per year from 
23 per 100,000 to 14 per 100,000 within the same time period.  
Malaria Surveillance 
 In Malawi, historical estimates of the malaria burden and malaria prevention behaviors 
have only been estimated at the regional level at single points in time, such as from cross-
sectional Demographic and Health Surveys (DHS) in 2010 and 2015/2016,45,46 and Malaria 
Indicator Surveys (MIS) in 2012, 2014, and 2017.35,47 Funded through USAID, DHS surveys are 
nationally-representative, randomized household surveys conducted in over 90 countries every 
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five years, collecting data on a multitude of heath indicators.48 DHS surveys obtain blood 
samples from adults for HIV testing purposes; though they do not test individuals for malaria 
infection, surveys capture information on malaria prevention and treatment behaviors. In 
contrast, MIS surveys are specific to malaria and conducted more frequently. MIS surveys test 
children <5 years for malaria infection using RDTs and microscopy, and collect data on malaria 
indicators through household surveys in nearly 30 countries.49 While both DHS and MIS national 
surveys randomly sampled households at a granular scale, they can only offer a high-level cross-
sectional glance at malaria prevalence among children and preventative behaviors (such as bed 
net ownership and use) in broad geographic locations. For example, MIS 2017 found a national 
malaria prevalence of 24% in children by microscopy and could only produce three broad 
prevalence measures for the Northern, Central, and Southern regions, as these surveys only 
generate reliable estimates down to the regional level.47 However, malaria in Malawi was proven 
to be geographically heterogenous at the sub-district level in the Northern region of the country 
from 2004-2006,50 and has even been shown to be heterogenous down to the household level 
within a rural area of a single district.51 Surveys also sample at specific points in time; DHS can 
take place at any time over the course of the year, and MIS is administered only during the high 
malaria transmission months; this temporal variation prohibits estimation of malaria patterns 
over both wet and dry seasons. DHS and MIS results have been compared in Cameroon and 
show varying malaria estimates when conducted in different transmission seasons.52 DHS was 
also unable to capture high malaria prevalence clusters in certain geographical spaces, revealing 
the limitations of single cross-sectional surveys in areas with seasonal patterns and varying 
ecosystems. Additionally, these surveys require extensive time and resources dedicated to active 
surveillance data collection efforts; the average cost of a DHS survey is $1.6 million, involving 
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active visits to 27,516 individual households.46,53 Other research involving P. falciparum age-
standardised annual parasite rates in children54 and predicted malaria risk across smaller land 
areas55 have traditionally only been able to achieve a more granular focus by relying on models 
based on survey data. 
 With the introduction of District Health Information Software 2 (DHIS2), used as a 
health management information system in Malawi since 2015, each health facility reports 
malaria case statistics (and other health indicators) to the Ministry of Health monthly. This 
enables ascertainment of population malaria counts to calculate cumulative incidence 
continuously over time through passive surveillance. DHIS2 is a system used in 72 low and 
middle-income countries, covering 2.3 billion people.56 The application is country-specific and 
web-based, but can be accessed offline.57 Users can control the interface to analyze data, 
generate reports, and add modules tailored to a country’s specific health needs. DHIS2 malaria 
data have already been analyzed in Uganda, Zimbabwe, and Kenya to determine the effect of 
interventions, assess DHIS2 monthly reporting completeness, and conduct spatial mapping 
studies.58–61 In Malawi, DHIS2 has been in use by the Ministry of Health since 2015. Health 
Surveillance Assistants collect community-level data on paper forms which are then sent to 
health facilities to be entered into registers.8 Patient data from registers are consolidated into de-
identified summary reports and submitted to the District Health Program Coordinator on paper 
forms, where data are verified and then entered electronically into DHIS2. Reports include 
outpatient aggregated counts on the number of positive microscopy and rapid diagnostic test 
results, outpatient data on the number of suspected and confirmed cases, inpatient data on the 
number of suspected and confirmed cases, the number of inpatient malaria deaths, number of bed 
nets distributed to pregnant women and babies, and the number of Lumefantrine-Artemether 
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treatments administered.8 Data are aggregated by health facility and month, and variables are 
stratified into children <5 years and persons ≥5 years.  
 In addition to collecting malaria case information, Malawi also administers insecticide 
resistance studies to determine the potential effectiveness of LLINs and IRS for future 
campaigns. Entomological monitoring takes place across various districts and is assessed by 
sampling mosquitoes of different species to determine sporozoite infection rates and to test 
susceptibility to various insecticides.62 In 2017, high levels of pyrethroid and carbamate 
resistance were found, indicating the need for future testing of additional insecticides.  
Innovation 
Malaria is geographically heterogeneous, and malaria risk measures in Malawi vary at a 
fine geographical scale.51 The proposed study would be the first to nationally evaluate malaria in 
Malawi at a sub-district level, using routinely collected health facility surveillance data to 
estimate variations in malaria cumulative incidence both geographically and temporally. 
Geographically granular estimates of malaria can be used to target interventions to specific 
villages, with ongoing surveillance data creating a natural opportunity to study how interventions 
affect malaria incidence over time. This will also be one of the first studies in Malawi to utilize 
DHIS2 data to study the effects of a health intervention. The design of this study will serve as a 
model for other countries that also use DHIS2 and whose governments could replicate this 
design for implementation of other health interventions through public and private health 
facilities. We are uniquely positioned to take advantage of this national data source to evaluate 
Malawi’s largest malaria prevention effort, making efficient use of time and resources already 
being allocated to ongoing passive surveillance.  
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Asymptomatic and submicroscopic malaria are thought to be important reservoirs for 
malaria transmission as asymptomatic infections persist for months, allowing more time for the 
parasite to transmit.22 This is the first molecular study in Malawi to create a national assessment 
of malaria infection among adolescents and adults. Assessment of asymptomatic malaria across 
Malawi and an analysis of risk factors will provide an understanding of the prevalence and 
spatial distribution of underlying infections to inform malaria prevention efforts and identify key 
target groups. Results can also serve as a baseline assessment for future evaluations of 
asymptomatic malaria prevalence following the 2021-2022 MDHS. In partnering with the 
Malawi Ministry of Health, our goal is to use malaria epidemiologic data to inform current 
interventions and future health policy and programs. Questions about granular risk measures at 
the health facility level, effects of LLIN mass distribution campaigns, and the prevalence of the 
asymptomatic malaria reservoir must be answered before population-level malaria policy 
decisions can be made, in order to fully grasp the benefits and long-term sustainability of 
interventions against infection.   
16 
 
CHAPTER THREE: ASYMPTOMATIC PLASMODIUM FALCIPARUM MALARIA 
PREVALENCE AMONG ADOLESCENTS AND ADULTS IN MALAWI, 2015-2016 1 
 
Introduction 
 Malaria remains a significant cause of morbidity and mortality in Malawi, with an 
estimated 7.0 million confirmed cases reported in 2018.32 Plasmodium falciparum is the most 
virulent of the malaria species, giving rise to 98% of infections in-country.32 While children 
report the highest proportion of clinical disease,3 adults are thought to be an important reservoir 
to sustained transmission due to persistent asymptomatic infection. Underlying infection is 
unlikely to be diagnosed and treated as individuals often do not exhibit signs and symptoms of 
disease and consequentially do not seek care. Even if an individual is tested, parasite densities in 
asymptomatic infections are usually low and may be undetectable by microscopy or rapid 
diagnostic test (RDT),4,63 further reducing the likelihood of diagnosis and treatment. 
Asymptomatic infections can persist for months and older age is associated with an increased 
duration of persistent infection, allowing the parasite the opportunity to transmit for a prolonged 
period of time.64 The annual P. falciparum parasite rate was estimated to be 18-19% in children 
ages 2-10 years in Malawi in 2015-2016,2 however, little is known about the prevalence of adult 
asymptomatic P. falciparum infection.  
 
1 This chapter previously appeared as an article in Scientific Reports. The original citation is as follows:  
Topazian HM, Gumbo A, Puerto-Meredith S, Njiko R, Mwanza A, Kayange M, Mwalilino D, Mvula B, Tegha G, 
Mvalo T, Edwards JK, Emch M, Pettifor A, Smith JS, Hoffman I, Meshnick SR, Juliano JJ. Aymptomatic 
Plasmodium falciparum malaria prevalence among adolescents and adults in Malawi, 2015-2016. Scientific Reports; 
2020. 10:18740. 
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 Malaria is geographically and temporally heterogenous. In Malawi, malaria risk has been 
found to be modified by several environmental factors, including elevation, rainfall, temperature, 
and proximity to active agriculture.5–7 Insecticide-treated bed nets (ITN) are Malawi’s primary 
vector control strategy,8 with bed nets given to all households with pregnant women, newborn 
babies, and to the general population every three years through mass distribution campaigns.9 
ITNs act as both a physical and chemical barrier to repel and kill mosquitoes which land on the 
net.26 Bed net use has been shown to have protective individual and community-level 
associations with P. falciparum infection in children under five living in Lilongwe, Malawi,65 
and more broadly across Africa,66 however these relationships have not been established among 
Malawian adults. In addition, malaria vectors have varying levels of resistance to different types 
of insecticide used on ITNs, such as alpha-cypermethrin, permethrin, and deltamethrin,62 
however, the effect of ITN insecticide type on malaria prevalence has not been assessed at the 
population level. 
 The objective of the current analysis is to characterize and identify changes in the 
prevalence of asymptomatic P. falciparum, due to demographic, environmental, and spatial risk 
factors in Malawian adolescents and adults ages 15-54 years. Using dried blood spots collected 
from the 2015-2016 Malawi Demographic and Health Survey (2015-16 MDHS), we conducted 
quantitative polymerase chain reaction (PCR) to detect parasitemia. We then identified risk 
factors for infection using data taken from the 2015-16 MDHS and other spatial and 
environmental information sources.67–69 A particular focus was placed on ownership and self-
reported use of bed nets. Understanding the prevalence and spatial distribution of underlying 
infection is essential for implementation and evaluation of future interventions. Molecular 
surveillance of P. falciparum in adults can be an important tool for Ministries of Health to 
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supplement ongoing collection of clinical data through national health management information 
systems and periodic national household surveys of malaria prevalence among children. 
Methods 
Study design and population 
 The 2015-16 MDHS was a cross-sectional, nationally-representative survey enrolling 
26,361 households, 24,562 individual female participants, and 7,478 individual male 
participants, from a total of 850 clusters between October 2015 and February 2016, during the 
annual transition between dry and rainy seasons.46 In addition to household and individual 
interviews, women ages 15-49 and men ages 15-54 were also asked to contribute dried blood 
spots (DBS), collected on filter paper, to measure HIV prevalence. Of the 15,125 eligible 
individuals who contributed DBS for HIV testing, 7,393 (48.9%) unique DBS cards were 
subsequently located and found to have enough sample remaining for use in the current study. 
Informed consent was obtained from all individuals and/or their parent or legal guardian for 
participation in the 2015-16 MDHS, collection and storage of DBS, and additional testing of 
their samples. Ethical approval for our analysis was obtained from Institutional Review Boards 
through the National Health Sciences Research Committee at the Malawi Ministry of Health 
(#19/08/2381) and the University of North Carolina at Chapel Hill (#19-2882), and all research 
was performed in accordance with relevant guidelines and regulations.  
DNA amplification and genotyping 
 DBS were punched into 96 well plates at UNC Project-Malawi and shipped to the 
University of North Carolina at Chapel Hill for testing. DNA was extracted from filter paper 
using Chelex and stored at -80°C. Further details on the DNA extraction protocol and PCR assay 
validation are included in the Technical Methods found in the Supplemental Material. We tested 
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each individual sample with a real time PCR assay targeting the P.f. lactate de-hydrogenase gene 
(pfldh) to identify individuals with P. falciparum malaria infection, our primary outcome.70 
Samples amplified with a PCR cycle threshold (CT) value above 39 were considered negative. 
Sensitivity analyses considered a range of CT value cut-offs to determine the impact of altering 
the sensitivity of the assay (Supplementary Figure A1).  
Spatial and ecological variables 
 De-identified 2015-16 MDHS survey and geospatial data were linked to each sample’s 
PCR results through random sample barcode. As part of the DHS methodology, GPS coordinates 
are collected in the field, marking the center of each cluster of households. The DHS program 
maintains participant confidentiality by displacing the GPS coordinates for all survey clusters: 
urban clusters are displaced up to a maximum of 2km and rural clusters up to 5km, with an 
additional 1% subset of rural clusters displaced up to 10km.71 PCR P. falciparum prevalence was 
mapped onto a smoothed surface using a constructed semivariogram and simple kriging to 
predict regional variation in malaria prevalence. Simple kriging assumes that observed malaria 
prevalence is spatially autocorrelated and that there is a known mean trend which is stationary 
across our study area. 
 Individual and cluster level risk factors were selected based on directed acyclic graphs 
and known associations from relevant literature.5–7,33,72 Individual level factors included sex, age 
group, wealth quintile, education level, owning livestock, source of drinking water, living in a 
household with a bed net, sleeping under a long-lasting insecticide-treated net (LLIN), LLIN 
insecticide type, living in a household with at least 1 net per 1.8 household members, and anemia 
(women only). Cluster level covariates included region, urban/rural place of residence, elevation, 
month of data collection, landcover, the proportion of a cluster with bed nets, and the proportion 
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of a cluster that slept under an LLIN. As transmission intensity is seasonal in Malawi, with peak 
transmission between January and May due to greater rainfall,9,34 we also examined 
environmental variables at the cluster level including current month’s average daily maximum 
temperature, and the prior month’s precipitation. Modeled monthly precipitation and monthly 
average daily maximum temperature raster files, created from both in-situ weather station data 
and satellite imagery, were acquired from the Climate Hazards Center at the University of 
California, Santa Barbara.67,68 Clusters were assigned precipitation and temperature values by 
averaging raster cells which fell within the 2km and 10km buffers surrounding urban and rural 
clusters, respectively, similar to DHS methodology for ecological variables.73 Land cover 
estimates were obtained from satellite imagery classified by the Regional Center for Mapping of 
Resources for Development and SERVIR-Eastern and Southern Africa into settlement areas, 
forest, grassland, cropland, wetland, and other land cover types.69 Clusters were assigned the 
majority land cover value within the 2km and 10km buffers surrounding urban and rural clusters. 
Statistical analysis 
 We estimated prevalence differences to quantify the associations between demographic 
and environmental risk factors and the probability of being infected with P. falciparum. To 
power findings within subgroups of interest, the DHS two-stage sampling design selects 
population clusters with unequal probability, followed by households within clusters, violating 
the independence of observations assumption in standard regression. Weighting individual 
observations is required to appropriately specify individual and group-level variation. We 
accounted for the 2015-16 MDHS complex sample survey design when estimating bivariate and 
multivariate associations using 2015-16 MDHS HIV sample weights incorporated into linear risk 
regression models fit using generalized estimating equations. As the subset of DBS used in this 
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analysis was not a simple random sample (Supplementary Table A4), we also incorporated 
standardized inverse probability of selection weights74 into regression models by calculating 
stabilized propensity scores for the probability of each individual being selected into the analysis 
based on their respective covariate pattern. Bivariate models were run between all risk factors 
and the malaria prevalence outcome, to determine high-risk populations and areas for targeted 
interventions. Multivariate adjusted analyses were performed to assess the association between 
bed net use, insecticide type, and malaria prevalence, after controlling for confounding variables, 
as bed nets have the potential for use in future interventions. Multivariate models were run 
among the total study population and in a sub-analysis of pregnant women. All weighted 
tabulations, models, and maps were run using R 3.6.2 (R Foundation for Statistical Computing, 
Vienna, Austria), using the survey (v3.35-1; Lumley, 2019) and sf (v0.9-2; Pebesma, 2020) 
packages.  
Results 
 Of all 7,393 samples analyzed, 2,125 were PCR-positive for P. falciparum, and 5,268 
were negative. After incorporating survey weights, the weighted P. falciparum prevalence was 
31.1% (standard error = 1.1) among adolescents and adults ages 15-54 (Table 3.1). Samples 
represented 497 out of 850 (58.5%) clusters. The median number of individuals per cluster was 
16 (IQR: 12 to 30; range 1 to 34). Over half of positive samples (55.6%) had parasitemias ≤10 
parasites/µL (Figure 3.1), and parasitemia was not correlated with age. The intra-class 
coefficient at the cluster level was 22.3%, indicating that individual risk is associated with 




Table 3.1 Characteristics of the study population, stratified by P. falciparum PCR status, 2015-






n % n % n % 
Unweighted total number* 5268   2125       
Weighted count proportion** 4799 68.9 2170 31.1 6969   
  
Individual level covariates**             
Sex 
Male 2191 45.7 1124 51.8 3315 47.6 
Female 2608 54.3 1045 48.2 3654 52.4 
Age group (years) 
15-24 1936 40.3 1096 50.5 3031 43.5 
25-34 1421 29.6 583 26.9 2004 28.8 
35-44 1004 20.9 349 16.1 1353 19.4 
45-54 439 9.1 142 6.5 581 8.3 
Wealth quintiles 
Poorest 712 14.8 530 24.4 1242 17.8 
Poorer 849 17.7 524 24.1 1372 19.7 
Middle 943 19.6 490 22.6 1433 20.6 
Richer 1004 20.9 366 16.9 1370 19.7 
Richest 1291 26.9 260 12.0 1551 22.3 
Education 
None/preschool 373 7.8 186 8.6 559 8.0 
Primary 2816 58.7 1525 70.3 4341 62.3 
Secondary 1381 28.8 442 20.4 1823 26.2 
Higher 209 4.4 12 0.5 221 3.2 
Owns livestock, herds, or farm animals 
No 2207 46.0 946 43.6 3153 45.2 
Yes 2593 54.0 1224 56.4 3816 54.8 
Source of drinking water 
Piped 1222 25.5 250 11.5 1472 21.1 
Unpiped 3577 74.5 1920 88.5 5497 78.9 
Household has a bed net 
No 1606 33.5 749 34.5 2355 33.8 
Yes 3193 66.5 1421 65.5 4614 66.2 
Slept under an LLIN last night 
No 3014 62.8 1408 64.9 4422 63.4 
Yes 1786 37.2 762 35.1 2547 36.6 
Insecticide of LLIN individual slept under 
(out of individuals sleeping under nets) 
Permethrin 1141 63.9 507 66.6 1649 64.7 
Non-
permethrin 
642 36.0 254 33.4 897 35.2 
At least 1 net per 1.8 household members 
No 731 15.2 243 11.2 975 14.0 




Anemia (women only) 
Not anemic 1821 69.8 628 60.1 2449 67.0 
Mild 601 23.1 327 31.3 929 25.4 
Moderate 173 6.6 81 7.8 254 7.0 
Severe 10 0.4 9 0.9 19 0.5 
  
Cluster level covariates**             
Region 
Northern 822 17.1 254 11.7 1076 15.4 
Central 1653 34.4 914 42.1 2567 36.8 
Southern 2325 48.4 1001 46.1 3326 47.7 
Place of residence 
Urban 941 19.6 152 7.0 1093 15.7 
Rural 3858 80.4 2018 93.0 5876 84.3 
Elevation (m) 
<500 719 15.0 287 13.2 1005 14.4 
≥ 500  & <1000 1673 34.9 1006 46.4 2678 38.4 
≥ 1000 & <1500 2217 46.2 849 39.2 3067 44.0 
≥ 1500 191 4.0 28 1.3 219 3.1 
Month of data collection 
October '15 867 18.1 635 29.3 1503 21.6 
November '15 1580 32.9 639 29.5 2219 31.8 
December '15 730 15.2 234 10.8 963 13.8 
January '16 1462 30.5 568 26.2 2029 29.1 
February '16 161 3.4 94 4.3 255 3.7 
Landcover 
Settlement 819 17.1 116 5.4 935 13.4 
Forest 605 12.6 313 14.4 917 13.2 
Grassland 333 6.9 185 8.5 518 7.4 
Cropland 2743 57.1 1410 65.0 4153 59.6 
Wetland 220 4.6 131 6.0 350 5.0 
Other 80 1.7 15 0.7 96 1.4 
  
    mean se mean se mean se 
Proportion of cluster with bed nets 64.4 0.9 63.6 1.1 64.2 0.8 
Proportion of cluster that slept under an LLIN last night 31.5 0.7 30.6 0.8 31.2 0.6 
Current month's average daily maximum temperature (°C) 31.1 0.1 31.5 0.1 31.2 0.1 
Prior month's precipitation (mm) 67.3 4.0 62.3 4.7 65.7 3.9 
* Counts do not incorporate sample weights, and are not representative of the weighted populations used in the 
table 
** Sampling weights applied 








Figure 3.1 Distribution of PCR P. falciparum positive parasitemia values (n=2,215). Values <10 
parasites/µL are rounded up to 10 parasites/µL. The density plot’s solid line represents a normal 
distribution using the observed counts.  
 
Demographics 
 After incorporating weights to account for survey design and selection bias, 52.4% of 
participants were female, 43.5% were between the ages of 15 to 24, and primary school was the 
highest level of education attended by 62.3% (Table 3.1). Most participants came from the 
Central (36.8%) and Southern regions (47.7%), and 84.3% were from rural areas. Most 
individuals (59.6%) were from clusters located on cropland. Data collection was spread unevenly 
across months, ranging from 3.7% of samples collected in February 2016 to 31.8% in November 
2015. Two-thirds (66.2%) of participants lived in a household with a bed net, but only 36.6% 
reported sleeping under a long-lasting insecticide-treated bed net (LLIN) the night prior; 64.7% 
under permethrin treated LLINs and 35.2% under non-permethrin (alpha-cypermethrin or 
deltamethrin) treated LLINs. Over half (52.2%) of individuals lived in households meeting the 
World Health Organization’s universal coverage criteria of a minimum of 1 net per 1.8 people.  
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 Simple kriging P. falciparum prevalence estimates ranged from 2.5% to 83.5% across 
Malawi, demonstrating high spatial heterogeneity (Figure 3.2). P. falciparum prevalence was 
higher in the Northeastern part of the country along the lakeshore, and in the central southern 
region near Ntcheu. Prevalence was lowest in the southern tip of Malawi and in the Northwest 
highland areas. Estimates should be interpreted regionally, as standard errors are high in areas 
where data do not exist.  
 
Figure 3.2 Spatial distribution of 2015-16 MDHS clusters. a) P. falciparum prevalence by 
cluster and cluster size, b) weighted P. falciparum prevalence by district, c) smoothed PCR P. 
falciparum prevalence estimates using simple kriging, d) smoothed P. falciparum standard error 
estimates using simple kriging. Clusters with fewer than five observations were removed prior to 
kriging to reduce the influence of extreme values due to small sample sizes. Smoothed surfaces 
are meant to demonstrate regional differences and should not be used for interpretation into areas 
where data do not exist. All maps were run using R 3.5.1 (R Foundation for Statistical 




Risk factor analysis 
 In weighted bivariate analysis, female sex was associated with a lower prevalence of P. 
falciparum infection (prevalence difference: -0.05, 95% confidence intervals: -0.08 to -0.03) 
(Table 3.2). Prevalence decreased as age increased and was lowest among those 45-54 years as 
compared to those 15-25 years (PD: -0.12, 95% CI: -0.17 to -0.06). Parasite prevalence was 
lower in urban versus rural areas (PD: -0.20, 95% CI: -0.24 to -0.17) and among populations 
with piped drinking water versus unpiped (PD: -0.18, 95% CI: -0.22 to -0.14). Other protective 
factors included greater wealth (PD: -0.26, 95% CI: -0.31 to -0.21, richest vs. poorest), higher 
education (PD: -0.28, 95% CI: -0.34 to -0.22, higher vs. none). Living in wetlands (PD: 0.25, 
95% CI: 0.15 to 0.34) and grasslands (PD: 0.23, 95% CI: 0.13 to 0.33) were associated with the 
highest prevalence of infection, as compared to settlement areas. Increased geographic average 
daily maximum temperature was associated with greater malaria prevalence (PD: 0.02, 95% CI: 
0.01 to 0.03 per 1°C increase). Individuals living at elevations between 500 and 1,000 meters 
above sea level, along the lake shore, had the highest prevalence of infection (37.6%), with 
lowest prevalence among those living at or above elevations of 1,500 meters above sea level 




Table 3.2 Bivariate associations between demographic and environmental risk factors and P. 














Male 0.339 - - - - 
Female 0.286 -0.05 -0.08 -0.03 <0.001 
Age group (years) 
15-24 0.361 - - - - 
25-34 0.291 -0.07 -0.11 -0.04 <0.001 
35-44 0.258 -0.10 -0.15 -0.06 <0.001 
45-54 0.245 -0.12 -0.17 -0.06 <0.001 
Wealth quintiles 
Poorest 0.427 - - - - 
Poorer 0.382 -0.05 -0.09 0.00 0.05 
Middle 0.342 -0.08 -0.14 -0.03 0.001 
Richer 0.267 -0.16 -0.20 -0.11 <0.001 
Richest 0.167 -0.26 -0.31 -0.21 <0.001 
Education 
None 0.332 - - - - 
Primary 0.351 0.02 -0.03 0.07 0.4 
Secondary 0.243 -0.09 -0.14 -0.04 0.001 
Higher 0.053 -0.28 -0.34 -0.22 <0.001 
Owns livestock, herds or farm 
animals      
No 0.300 - - - - 
Yes 0.321 0.02 -0.01 0.05 0.2 
Source of drinking water 
Piped 0.170 - - - - 
Unpiped 0.349 0.18 0.14 0.22 <0.001 
Household has a bed net 
No 0.318 - - - - 
Yes 0.308 -0.01 -0.04 0.02 0.6 
Slept under an LLIN last night 
No 0.318 - - - - 
Yes 0.299 -0.02 -0.05 0.01 0.2 
Insecticide of LLIN individual 
slept under (out of individuals 
sleeping under nets) 
Permethrin 0.308 - - - - 
Non-
permethrin 
0.284 -0.02 -0.08 0.03 0.4 
At least 1 net per 1.8 household 
members 
No 0.249 - - - - 
Yes 0.324 0.07 0.03 0.12 0.001 
Number of months ago that 
sleeping net was obtained (treated 
or untreated) 
<12 0.302 - - - - 
12-23 0.294 -0.01 -0.07 0.05 0.8 
24-35 0.281 -0.02 -0.10 0.06 0.6 
≥36 0.265 -0.04 -0.09 0.02 0.2 
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Anemia (women only) 
Not anemic 0.256 - - - - 
Mild 0.352 0.10 0.05 0.14 <0.001 
Moderate 0.319 0.06 -0.01 0.14 0.1 
Severe 0.478 0.22 -0.05 0.49 0.1 
Region 
Northern 0.236 - - - - 
Central 0.356 0.12 0.07 0.17 <0.001 
Southern 0.301 0.06 0.01 0.12 0.02 
Place of residence 
Urban 0.139 - - - - 
Rural 0.343 0.20 0.17 0.24 <0.001 
Elevation (m) 
<500 0.285 - - - - 
≥ 500  & 
<1000 
0.376 0.09 0.03 0.16 0.007 
≥ 1000 & 
<1500 
0.277 -0.01 -0.07 0.05 0.8 
≥ 1500 0.127 -0.16 -0.23 -0.09 <0.001 
Month of data collection 
October '15 0.423 - - - - 
November '15 0.288 -0.13 -0.21 -0.06 <0.001 
December '15 0.243 -0.18 -0.26 -0.10 <0.001 
January '16 0.28 -0.14 -0.21 -0.08 <0.001 
February '16 0.369 -0.05 -0.16 0.06 0.3 
Landcover 
Settlement 0.124 - - - - 
Forest 0.341 0.22 0.14 0.29 <0.001 
Grassland 0.356 0.23 0.13 0.33 <0.001 
Cropland 0.34 0.22 0.18 0.25 <0.001 
Wetland 0.373 0.25 0.15 0.34 <0.001 
Other 0.16 0.04 0.00 0.07 0.03 
Proportion of cluster with bed 
nets (scaled) 
Mean 0.311 - - - - 
10% increase - -0.01 -0.02 0.01 0.4 
Proportion of cluster that slept 
under an LLIN last night (scaled) 
Mean 0.311 - - - - 
10% increase - -0.01 -0.03 0.00 0.2 
Current month's average daily 
maximum temperature (°C) 
(scaled) 
Mean 0.311 - - - - 
1°C increase - 0.02 0.01 0.03 <0.001 
Prior month's precipitation (mm) 
(scaled) 
Mean 0.311 - - - - 
100 mm 
increase 
- -0.02 -0.05 0.01 0.2 
Note: LLIN = long-lasting insecticide treated net 
 
 After adjusting for age, sex, wealth, and household size, there was no difference in the 
prevalence of infection between households with and without bed nets (PD: 0.02, 95% CI: -0.02 
to 0.05) or between individuals who reported sleeping under an LLIN the previous night and 
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those who did not (PD: 0.01, 95% CI: -0.02 to 0.04) (Table 3.3). After adjusting for age, sex, 
and wealth, sleeping under a non-permethrin versus permethrin treated LLIN (PD: -0.02, 95% 
CI: -0.07 to 0.02) was not protective. However, a sub-analysis among the study population’s 319 
pregnant women showed a protective prevalence difference between those who slept under non-
permethrin treated LLINs, including alpha-cypermethrin and deltamethrin, (PD: -0.16, 95% CI: -
0.34 to 0.02) as compared to permethrin treated LLINs (Table 3.4), although this did not reach 
statistical significance. Meeting the WHO universal coverage criteria of 1 net per 1.8 household 
members was not protective in either population. Community-level household bed net coverage 
and the community-level proportion who slept under an LLIN were not protective against P. 
falciparum infection in the general population. 
 Sensitivity analyses defining malaria positivity as PCR amplification which crossed the 
threshold line below CT values of 37 and 38 found similar relationships between covariates and 




Table 3.3 Multivariate associations between bed net associated risk factors and P. falciparum 








Household has a bed net 
Unadjusted -0.01 -0.04 0.02 0.6 
Adjusted* 0.02 -0.02 0.05 0.3 
Slept under an LLIN last night 
Unadjusted -0.02 -0.05 0.01 0.2 
Adjusted* 0.01 -0.02 0.04 0.6 
Individual slept under LLIN treated 
with non-permethrin (vs. permethrin) 
Unadjusted -0.02 -0.08 0.03 0.4 
Adjusted† -0.02 -0.07 0.02 0.4 
At least 1 net per 1.8 household 
members 
Unadjusted 0.07 0.03 0.12 <0.001 
Adjusted§ 0.02 -0.01 0.06 0.2 
* models adjusted for age, sex, wealth, and household size 
† model adjusted for age, sex, and wealth 
§ model adjusted for wealth and district  
Note: LLIN = long-lasting insecticide treated net 
 
 
Table 3.4 Multivariate associations between bed net associated risk factors and P. falciparum 
prevalence using weighted survey data among pregnant women in the 2015-16 MDHS who 








Household has a bed net 
Unadjusted -0.09 -0.21 0.03 0.2 
Adjusted* -0.09 -0.21 0.03 0.1 
Slept under an LLIN last night 
Unadjusted -0.06 -0.20 0.07 0.4 
Adjusted* -0.06 -0.19 0.08 0.4 
Individual slept under LLIN treated 
with non-permethrin (vs. permethrin) 
Unadjusted -0.19 -0.37 -0.02 0.04 
Adjusted† -0.16 -0.34 0.02 0.08 
At least 1 net per 1.8 household 
members 
Unadjusted 0.02 -0.15 0.18 0.8 
Adjusted§ 0.03 -0.09 0.15 0.6 
* models adjusted for age, wealth, and household size 
† model adjusted for age and wealth 
§ model adjusted for wealth and region 





 This study represents the first national survey in Malawi to determine P. falciparum 
infection in adolescents and adults. Nearly a third of individuals ages 15-54 are infected with P. 
falciparum, primarily with low-density infections undetectable through microscopy or RDT. 
Protective factors against asymptomatic P. falciparum infection include older age, urban 
residence, greater wealth, higher education, and lower geographic average daily maximum 
temperature. Living in a household which owned a bed net and reporting sleeping under an LLIN 
were not protective against infection among our study population, even after stratifying by 
insecticide type. However, among pregnant women, sleeping under alpha-cypermethrin or 
deltamethrin-treated nets appeared protective, as compared to permethrin treated nets. 
Underappreciating the significance of the extensive reservoir of asymptomatic infection among 
adolescents and adults neglects an important source of sustained P. falciparum transmission in 
Malawi and hinders understanding of key target groups for intervention. 
 Demographic and environmental risk factors associated with P. falciparum infection 
among adolescent and adults in our study resemble those previously found among asymptomatic 
children and individuals of all ages presenting with clinical symptoms; these risk factors in 
Malawi include low elevation, higher temperatures, younger age, rurality, and region.5–7 Similar 
to the cross-sectional nationally representative Malawi Malaria Indicator Surveys (MIS) among 
children in 2014 and 2017,35,75 the highest malaria prevalence was found in the Central region, 
followed by the Southern and Northern regions, although results are likely influenced by regional 
data collection during different months of the year (Supplementary Table A9). The national 
prevalence estimate of 31% in our study is comparable to results using similar methodology 
among adults from the Democratic Republic of the Congo in 2007 and 2014, which also found 
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that younger age, male sex, and lower wealth indicators were risk factors for increased 
infection.76,77 Our prevalence estimate is much higher than modeling predictions of P. falciparum 
annual parasite rates of 18-19% in children 2-10 years in 2015-2016, however these predictions 
were generated from multiple community-based survey measurements in the literature and from 
other unpublished sources which used RDT and microscopy as opposed to PCR.2 While 
prevalence estimates were high, parasitemia values were low among our study population; 
however this finding is consistent with research showing that malaria infection is more likely to 
be submicroscopic among older children and adults versus younger children, hypothesized to 
stem from acquired immunity.21 Risk factor analysis is important for identifying key populations 
to target for malaria prevention and control, and our results suggest that malaria prevention 
measures might be best focused towards men, younger age groups, poor communities, and rural 
areas.  
 Surprisingly, household ownership of bed nets, individual use of LLINs for sleeping, 
owning 1 net per 1.8 household members, and community bed net coverage were not associated 
with asymptomatic P. falciparum prevalence. While two-thirds of individuals resided in 
households which owned bed nets, only 36.6% reported sleeping under an LLIN the previous 
night, indicating low LLIN usage. Prevalence was higher among men as compared to women; 
females have been shown to clear asymptomatic P. falciparum infections faster than males, 
leading to the appearance of lower infectivity, and highlighting the importance of biological 
differences.78 Other reasons for prevalence differences between males and females could relate 
to gender norms and behavioral factors around sleeping arrangements, gender-differentiated 
access to education about malaria or treatment and screening services, and gendered division of 
outdoor labor.79  
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 Bed net ownership and use indicators were not associated with P. falciparum prevalence 
among our overall study population but insecticide type was found to have a near protective 
association among pregnant women. Pregnant women had similar patterns of sleeping under an 
LLIN the previous night as compared to the overall study population (38.7% vs. 36.6% 
respectively), however of those who slept under LLINs, 43.6% of pregnant women used nets 
treated with alpha-cypermethrin or deltamethrin, compared with 35.2% in the general population. 
Additionally, 49.0% of the nets used by pregnant women for sleeping were less than one year 
old, compared with 37.2% in the general population. While the general population receives bed 
nets every three years as part of regular mass distribution campaigns, Malawi’s National Malaria 
Control Programme has given out free LLINs to pregnant women through antenatal care clinics 
since 20069 with 79-87% of pregnant women who attended antenatal clinics receiving LLINs in 
2015-16.9 Although WHO recommendations allow for up to three years between mass 
distribution campaigns,80 field research in Benin, Malawi, Rwanda, Senegal, and Tanzania 
suggests that ITNs have a limited lifespan of two years before protection is compromised by 
holes, insecticide-resistance, and reduced concentrations of insecticide.37,81–84 In Burkina Faso, a 
third of people had stopped using LLINs within a year of distribution.85 Pregnant women in our 
study appear to have been the recipients of relatively newer nets which might have greater 
effectiveness, while households without pregnant women would have primarily received nets 
through Malawi’s first national mass distribution campaign in 2012, or through limited follow-up 
mop-up campaigns in six districts in 2014.30  In areas where nets are used at night, there is also 
evidence to suggest that long term use of insecticides inside the home can shift Anopheles spp. 
mosquitos from indoors to outdoors host seeking behavior, increasing the likelihood of an 
individual becoming infected, and perhaps contributing to reduced effectiveness of LLINs 
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against malaria.86,87 Bed net durability and mosquito biting behavior were not measured as part 
of the 2015-16 MDHS, but could have contributed to the lack of association found between net 
ownership and use, and malaria prevalence among our study population.  
 The major strength of this study is the efficient use of a large number of nationally 
collected samples from adolescents and adults, a population which is understudied in malaria 
transmission research. Using molecular and epidemiologic methods, we better characterized the 
reservoir of asymptomatic P. falciparum, a pool of infection which is likely contributing to 
sustained transmission in Malawi. The results presented can serve as baseline assessment; 
repeated use of DHS samples over time can create a picture of shifting trends across the entire 
country while using resources cost-effectively to supplement intermittent MIS iterations 
estimating malaria prevalence among children. Characterizing the prevalence of P. falciparum 
among adults and identifying key target groups will be informative as the Malawi Ministry of 
Health designs future mass distribution campaigns and other interventions against malaria.  
 The primary limitation of this analysis is the cross-sectional nature of available samples. 
The 2015-16 MDHS captured DBS from participants at a single time point, allowing for 
estimation of marginal associations between risk factors and infection to identify groups at high 
risk, but limiting evaluation of causal relationships. Additionally, the samples used in the study 
were collected during the 2015-16 MDHS survey period from October to February, limiting 
inference to the remainder of the year and hindering comparison with published prevalence 
estimates among children from different time periods; however, as the study period occurred 
during the transition from dry to rainy season, we anticipate that results are somewhat 
representative of a yearly average. We used inverse probability of selection weights to make our 
results generalizable to the broader DHS cohort, but additional bias could still result due to 
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unmeasured confounding. Our analysis was also constrained by the aggregated geographical 
classification of individuals. As part of DHS methodology, individuals are geolocated at the 
center of their study cluster, which is then displaced up to 5km for 99% of rural clusters and 2km 
for urban clusters. There is an inherent lack of precision in land cover, temperature, and 
precipitation data, nonetheless, our methods attempt to account for geographic displacement by 
using average values falling within a cluster’s potential buffer area. Although our study measures 
presence of P. falciparum, we were not able to ascertain the presence of gametocytes within each 
infection, limiting the extent to which we can predict how these infections continue to sustain 
transmission. Results from elsewhere in Africa show that infection with P. falciparum 
gametocytes is associated with low asexual parasite densities and asymptomatic disease.4 
Comparisons between microscopy and PCR have found that microscopy can miss over 90% of 
gametocyte carriers due to limited sensitivity for low-density infections,22 further highlighting 
the importance of molecular surveillance tools in understanding infection transmission dynamics 
in this population.  
 Despite existing limitations, this analysis provides valuable input into an understudied yet 
critical group to consider in efforts to interrupt ongoing malaria transmission. Malawi spent an 
estimated $82 million on malaria control in 201688 and malaria accounts for 30% of all 
outpatient visits and 34% of inpatient hospital admissions.9 Households often amass high direct 
and indirect costs due to clinical malarial disease, despite free diagnosis and treatment.89 One of 
the primary goals of the Malawi Malaria Strategic Plan 2017-2022 is to achieve universal LLIN 
coverage for all households.9 Research from Madagascar shows that while LLIN mass 
distribution campaigns may only provide community protection for one year, protection can be 
sustained when campaigns are followed by continuous LLIN distribution to eligible households, 
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including recently married couples, immigrants, children of vaccination age, and homes with 
uncovered sleeping areas.90 Malawi could benefit from education on consistent and correct use of 
bed nets, and through expansion of continuous LLIN distribution services to additional 
populations beyond pregnant women, targeting younger individuals living in rural areas with 
high prevalence of infection for more frequent net replacement. Treating malaria at the 
population level through mass drug administration can clear parasite presence and prevent 
transmission of gametocytes from asymptomatic infections. However, mass drug administration 
is only recommended in settings considering malaria elimination, and requires low malaria 
prevalence, effective vector control, access to treatment, and extensive community participation 
as prerequisites for implementation.91,92  
 This study presents unique insight into the national prevalence of asymptomatic P. 
falciparum infection among adolescent and adults in Malawi. Use of molecular and 
epidemiological surveillance methods in tandem demonstrates that demographic and 
environmental risk factors for infection parallel those found in children and among individuals 
with symptomatic disease. Within the current framework of mass distribution frequency and 
community education, presence of bed nets in the household and use of LLINs by the individual 
did not appear to provide protective benefits, regardless of insecticide type, most likely due to 
bed net age and low frequency of use. Results from this study provide valuable guidance to 
decision makers in Malawi as the National Malaria Control Programme designs bed net 
distribution programs following mid-term review of the 2017-2022 National Malaria Control 
Strategy. Future work to replicate this analysis following the 2021-22 MDHS will enable 
assessment of changes in asymptomatic P. falciparum prevalence and other genetic markers in 
adolescents and adults across time.   
37 
 
 CHAPTER FOUR: EFFECTIVENESS OF A NATIONAL MASS 
DISTRIBUTION CAMPAIGN OF LONG-LASTING INSECTICIDE-TREATED NETS 
ON CLINICAL MALARIA IN MALAWI, 2018-2020 
 
Introduction 
 Malaria is endemic in Malawi, accounting for 30% of outpatient visits and 34% of 
inpatient admissions in-country.9 Historically, national malaria measures have been exclusively 
estimated cross-sectionally, such as through USAID-funded Malaria Indicator Surveys (MIS) in 
2012, 2014, and 2017. MIS are designed to offer a high-level glance at malaria prevalence 
among children 6-59 months in Malawi’s three regions, however, malaria in Malawi is known to 
be geographically heterogenous at the sub-district level,50 varies at the household level,51 and 
differs across age groups and seasons. MIS surveys only sample during high malaria 
transmission months, prohibiting estimation of how patterns fluctuate over the course of the year, 
and require extensive time and resources dedicated to active data collection. Other research 
involving annual parasite rates in children54 and predicted risk across smaller land areas55 have 
only achieved a detailed focus by modeling survey data. 
 Through District Health Information Software 2 (DHIS2), a health management 
information system used in Malawi since 2015, each health facility reports paper-based monthly 
composite statistics to the Ministry of Health. Malaria data includes total confirmed case counts 
for persons <5 years of age and ≥5 years of age each month, which can be used to track the 
burden of disease continuously over time through passive surveillance. Similarly constructed 
DHIS2 malaria data have already been analyzed in Uganda, Zimbabwe, and Kenya to determine 
the effects of vector control and artemisinin-based combination therapy, assess DHIS2 reporting 
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completeness, and map the spatial distribution of malaria  by district.59–61 At present, Malawi’s 
DHIS2 malaria data have only been assessed at the district and national levels, recording 7.0 
million confirmed cases in 2018.32 No analyses have been conducted at the health facility level, 
providing the detail necessary to target local areas for intervention. 
 Long-lasting insecticide-treated bed nets (LLINs) are integral to Malawi’s malaria 
prevention efforts, alongside broad use of rapid diagnostic tests (RDTs) and artemisinin-based 
combination therapies, and fundamental to achieving the reduction goals outlined in Malawi’s 
Malaria Strategic Plan 2017-2022. LLINs provide a physical and chemical barrier to mosquito 
bites, and nets treated with various insecticides are selected for implementation based on vector-
resistance and cost. Implementation occurs through mass distribution campaigns and continuous 
distribution to pregnant women at antenatal care visits and to newborns following birth.9 
Insecticide-treated nets (ITNs) provide individual and community level protective benefits within 
a year of distribution,65 but there is no consensus on the maximum LLIN lifespan. World Health 
Organization recommendations suggest conducting mass distribution campaigns every three 
years,80 however, field research in Eastern, Southern, and Western Africa suggests that nets may 
have a much shorter lifespan, and rapidly become ineffective due to holes, reduced 
concentrations of insecticide, and repurposing.81–83,93 Prior research on mass distribution 
campaign effectiveness in Malawi has been limited by the use of cross-sectional survey data37 
and narrow geographic range.94  
 We present the first national longitudinal analysis of confirmed malaria risk at the health 
facility level, using DHIS2 to estimate geographical and temporal variations from January 2018 
to June 2020 by month and age strata. We assess risk before and after a mass bed net distribution 
campaign in late 2018 and stratify by intervention type including pyrethroid-treated nets, 
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piperonyl butoxide (PBO)-treated nets, and indoor residual spraying (IRS). Given that DHIS2 is 
now routinely used in 72 low-and middle-income countries, capturing metrics from 2.3 billion 
people,56 this study design and analysis can be replicated across the globe to inform national and 
regional health policies for malaria and other diseases. 
Methods 
Study design and population 
 Malawi’s population was over 17.5 million in 2018, with 2.6 million (15%) under the age 
of 5 years.95 The entire population lives in moderate to high malaria transmission zones and are 
at risk of acquiring infection. The outcome of interest was monthly confirmed malaria 
cumulative incidence (cases/population). Cases included individuals presenting at health 
facilities with a confirmed malaria diagnosis captured through DHIS2 from January 2018 
through June 2020. Confirmed cases are recorded as aggregated monthly counts at the health 
facility level within strata of age, test result, and other variables; DHIS2 contains no individual-
level patient data. Population estimates were extracted from WorldPop population distribution 
data.10 Although it is possible for an individual to experience more than one malaria episode per 
month, we expected these instances to be rare, and refer to cumulative incidence as “risk” for 
simplicity. The exposure of interest was the 2018 LLIN mass distribution campaign.  
 Ethical approval was obtained from Institutional Review Boards through the National 
Health Sciences Research Committee at the Malawi Ministry of Health (#19/08/2381) and the 
University of North Carolina at Chapel Hill (#19-2882).  
DHIS2  
 Malawi DHIS2 data are available at the health facility level from 2018 onward. Indicators 
were summed within age groups to create aggregate counts of malaria cases confirmed through 
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microscopy or RDT in the following settings: outpatient, inpatient, and community village health 
clinic (applicable to children <5 years). DHIS2 captures data from both public and private health 
facilities but does not capture asymptomatic cases, symptomatic cases that do not present for 
care, individuals who die at home without a diagnosis, and those that seek diagnostic and 
treatment services through traditional medicine. 
 A total of 756 facilities recorded data in 2018, 925 in 2019, and 926 as of June 2020, 
resulting in 25,099 total observations (Figure 4.1). Health facilities were linked to geographic 
coordinates through existing data sources96 and cross-referenced using Google Maps and 
OpenStreetMap. Health centers with duplicate coordinates and names were combined into single 
entries. This analysis included 711 facilities with DHIS2 data in 2018, 2019, and 2020, 
encompassing 20,962 (of 25,099; 83.5%) total health facility reports, but capturing 97.1% (16.6 





Figure 4.1 Health facilities and facility reports from Malawi’s District Health Information 
Software 2 which were included in the analysis, January 2018 to June 2020. 
 
Spatial analysis and population measurements 
 Population estimates were derived from the WorldPop project which releases population 
raster maps modelled from census counts, nighttime lights, settlement buildup, landcover, roads, 
and other variables, downscaled to 100x100m grid squares, and stratified by <5 and ≥5 year age 
groups.10 Since existing WorldPop rasters were created using UN population projections based 
on the 2008 Malawi census, we used an open-source algorithm97 to recalculate up-to-date 
estimates using 2018 census counts within each Traditional Authority boundary.98  
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 To determine population denominators for each health facility, we delineated catchment 
areas using Thiessen polygons (Figure 4.2). A Thiessen polygon is defined as a region that 
contains all areas that are closer to a particular point (health facility) than to any other 
neighboring points. These catchment areas were overlaid on the recalculated WorldPop rasters 




Figure 4.2 Health facility catchment areas for health facilities with data in Malawi’s District 
Health Information Software 2 in 2018-2020 (n=711), calculated by Euclidean distance using 
Thiessen polygons. 
 
 Longitudinal environmental data were used to assess bias in malaria risk estimates 
between years. We used Climate Research Unit gridded Time Series (CRU TS) v.4 which 
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interpolates values from in-situ weather station data to create national monthly estimates of 
average temperature and total precipitation.99  
Bed net mass distribution campaign 
 Malawi’s most recent mass distribution campaign took place from September to 
December 2018, allocating LLINs across 27 of Malawi’s 28 districts. Each district administered 
either permethrin-  or deltamethrin- (Olyset® or Permanent®; “pyrethroid”) treated nets, or 
permethrin + PBO-treated nets (Olyset® Plus; “PBO”), with one district, Mchinji, distributing 
both (Figure 4.3). Mchinji was assigned pyrethroid-treated nets in analyses of risk, as 69.4% of 
LLINs were pyrethroid-treated. Net type assignment was determined by assessment of malaria 
burden and population size within each district, but there was no association between 
intervention assignment and baseline 2018 malaria risk either at the health facility (p=0.3) or 
district levels (p=0.3). Health facilities coordinated household distribution via centralized 
locations within their catchment areas such as primary schools, health posts, and churches. 
LLINs were distributed by 648 health facilities and 602 (of 648, 92.9%) were linked to DHIS2 
and used in the health facility level risk analysis. All distribution facilities were included in 
district level calculations. Due to a national shortage of nets, one district, Nkhotakota, was 
assigned to receive IRS instead of LLINs. Mangochi received pyrethroid-treated nets in 2018 and 
IRS in 2019 but was not included in adjusted modeling. IRS with pirimiphos-methyl CS was 
administered from October to November 2018, and pirimiphos-methyl CS & clothianidin from 





Figure 4.3 Distribution of insecticide-treated nets from September to December 2018 during 
Malawi’s mass distribution campaign, and implementation of IRS in October and November 
2018 and in November and December 2019. A) Assigned intervention and insecticide type by 
district. * Mchinji distributed 69.4% pyrethroid-treated nets and 30.6% PBO-treated nets,  † IRS 
in 2019 only. B) Density of nets (number of nets per person) by health facility catchment area. * 
values >1 set to 1.  
Note: IRS = indoor residual spraying, PBO = piperonyl butoxide.  
 
Statistical analysis 
 Risk values at each health facility and district were visualized using maps and graphs 
stratified by time and age group. Risk differences were calculated by comparing risk in high 
(January to May) and low (June to December)9 transmission seasons before and after the 2018 
mass distribution campaign. Quasi-poisson regression models were used to estimate and compare 
risks under scenarios where all health facilities received pyrethroid-treated nets, PBO-treated 
nets, or IRS. Models adjusted for baseline 2018 malaria risk and LLIN coverage, and the delta 
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method was used to estimate 95% confidence intervals. DHIS2 2018 risk values were compared 
to 2017 estimates of Plasmodium falciparum parasite rates in children ages 2 to 10 years, 
modeled using MIS results and local survey data,8 in order to compare risk estimates to 
prevalence estimates from similar time periods by district. All tabulations, models, and maps 
were run using R 3.6.2 (R Foundation for Statistical Computing, Vienna, Austria) and the sf 
(v0.9-2; Pebesma, 2020) and ggalt (v0.4.0; Rudis, 2017) packages. 
Role of the funding source 
 The funders had no role in the study design, data collection, analysis, interpretation, or 
writing. All authors had full access to the data in the study and had final responsibility for the 
decision to submit for publication. 
Results 
 The analysis included 711 health facilities; the majority (580/711, 81.6%) reported data 
for the entire 30-month study period and nearly all facilities (709/711, 99.7%) reported data for 
at least 24 months. Over 10.7 million bed nets were distributed in 2018; 1 net was distributed for 
every 1.6 (range: 1.3-2.2) people nationally (Supplementary Table B2). Nkhotakota sprayed 
112,264 structures with insecticide in 2018, resulting in a coverage rate of 95%.32 IRS coverage 
in 2019 was 89% in Nkhotakota (population = 393,077) and 78% in Mangochi (population = 
1,148,611).  
 Risk varied geographically and seasonally among all age groups, with elevated estimates 
during high transmission seasons nationally and year-round along the shores of Lake Malawi 
(Figure 4.4). Risk was higher among children <5 years than among individuals ≥5 years and 
seemed to be heterogenous within district boundaries, indicating that aggregate measures across 





Figure 4.4 Monthly median risk of malaria (cases per 100 people) by high (January to May) and 
low (June to December) malaria transmission season and health facility catchment area, 2018-
2020, among A) the total population, B) children <5 years, and C) individuals ≥5 years of age. 
Confirmed case data are taken from Malawi’s District Health Information Software 2 and 
population denominators from adapted WorldPop 2018 estimates. * risk values >50 are set at 50 
cases per 100 people. 
 
 During high transmission seasons, there were 4.3 million recorded malaria cases 
nationally in 2018, 3.0 million in 2019, and 4.1 million in 2020. Spanning all seasons, there were 
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6.8 million cases in 2018 and 5.1 million in 2019, an overall annual reduction of 1.7 million 
cases following the LLIN campaign. Malaria risk was lower during high transmission months in 
2019 as compared to 2018, an association which held for all age groups and intervention types 
(Figure 4.5, Supplementary Table B3). Risk rebounded across all groups during the 2020 high 
transmission season, except for areas receiving IRS. Malaria risk in high transmission seasons 
decreased from 25.6 cases per 100 people in 2018 to 16.7 cases per 100 people in 2019 (Table 
4.1), a crude risk difference of -8.9. Confidence intervals were precise to one tenth of a percent 
due to the thousands of individuals included in each age group. Risk increased up to 23.2 cases 
per 100 people in 2020, with a seasonal risk difference of -2.4 comparing 2018 and 2020. 
Variations in risk were greater among children <5 years with seasonal risk differences of -30.2 
and -16.8 cases per 100 people, comparing risk in 2019 and 2020 to 2018, respectively; estimates 
among individuals ≥5 years showed similar trends (-5.3 and 0.1). Malaria risk was less varied 
during low transmission seasons, with seasonal risk differences of -8.0, -1.4, and -2.4 cases per 







Figure 4.5 Risk of malaria (cases per 100 people) from January 2018 to June 2020, stratified A) 
by age group, and B) by insecticide type. ‘No data’ refers to health facilities which did not have 
any bed net distribution or IRS information. Dark gray color blocks represent months where the 
mass distribution campaign occurred (September to December 2018) and light gray blocks 
represent months which fall during the yearly high malaria transmission season (January to 
May). Risk was measured monthly and curves are smoothed using X-splines. Note: IRS = indoor 
residual spraying, PBO = piperonyl butoxide. 
 
IRS: 1 district; 22 health facilities; 387,523 people; PBO: 9 districts; 127 health facilities; 
3,150,863 people; Pyrethroid: 17 districts; 423 health facilities; 10,854,018 people; Pyrethroid 






Table 4.1 Risk of malaria (cases per 100 people) by high (January to May) and low (June to 
December) malaria transmission seasons, stratified by age group and insecticide type, January 
2018 to June 2020. High transmission estimates represent 5-month risks, low transmission 
estimates represent 7-month risks.  
 




(cases per 100 people) (cases per 100 people) 
    2018 2019 2020 RD 2019 
vs. 2018 
RD 2020    2018 2019 RD 2019  









 <5 years 76.5 46.4 59.7 -30.2 -16.8   46.5 38.4 -8.0 
≥5 years 16.9 11.6 17.0 -5.3 0.1   8.8 7.4 -1.4 













IRS 46.1 17.0 20.0 -29.1 -26.1   44.0 34.4 -9.6 
Pyrethroid 26.8 20.5 28.6 -6.3 1.9   14.3 13.0 -1.3 
PBO 28.6 11.2 22.4 -17.4 -6.2   18.8 9.7 -9.1 
Pyrethroid / IRS 22.8 19.7 8.2 -3.2 -14.6   14.1 15.8 1.8 
No data 7.8 4.5 6.2 -3.3 -1.6   3.4 3.5 0.0 
* High transmission season: January to May; Low transmission season: June to December 
IRS = indoor residual spraying, PBO = piperonyl butoxide, RD = risk difference 
 
 
 Risk followed a similar pattern of decline and rebound when stratified by LLIN type. 
Administration of PBO-treated nets resulted in risk differences of -17.4 and -6.2 comparing 2019 
and 2020 to 2018 high transmission seasons, followed by pyrethroid-treated nets (-6.3 and 1.9). 
Use of IRS sustained protection, with a risk difference of -29.1 cases per 100 people comparing 
2019 and 2018 high transmission seasons and a risk difference of -26.1 comparing 2020 and 
2018. In Mangochi, pyrethroid-treated nets somewhat reduced risk in 2019 (RD: -3.2), but IRS 
spraying in 2019 dramatically reduced risk in 2020 (RD: -14.6). IRS and PBO-treated nets 
moderately reduced risks during the 2019 low transmission season (RD: -9.6, -9.1) relative to 
2018, but there was minimal change in areas receiving pyrethroid-treated nets (RD: -1.3). 
 Implementation of IRS, PBO-, and pyrethroid-treated nets resulted in varying effects by 
district (Figure 4.6, Supplementary Figure B1). Ntchisi, receiving PBO-treated nets, 
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underwent the greatest reduction in risk of -38.4 cases per 100 people comparing high 
transmission seasons in 2019 and 2018 (Supplementary Table B4). Overall, 12 of the 28 
districts (42.9%) experienced increases in malaria risk between 2018 and 2020 high transmission 
seasons. Nkhotakota, receiving IRS, experienced the greatest reduction in risk (-26.1) between 
2018 and 2020 high transmission seasons. 
 
 
Figure 4.6 Risk of malaria (cases per 100 people) and risk differences from 2018 to 2019 and 
2020, stratified by district and type of intervention. Data are shown for months falling within the 
high malaria transmission season (January to May), and estimates represent 5-month risks. Risk 
difference point values and 95% confidence intervals are shown by black dots and lines 
underlying each colored point, although confidence intervals are not readily visible because of 
the narrow range. Mchinji’s net distribution was comprised of 69.4% pyrethroid-treated nets and 
30.6% PBO-treated nets. Note: IRS = indoor residual spraying, PBO = piperonyl butoxide.  
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 We estimate that, if all districts had received pyrethroid-treated nets, malaria risk would 
have been 5.1 cases per 100 people (95% CI: 4.8 to 5.3) in 2019 and 7.1 (95% CI: 6.8 to 7.4) in 
2020 high transmission seasons. If all districts had received PBO-treated nets, malaria risk would 
have been lower in both years at 2.8 (95% CI: 2.5 to 3.1) and 5.6 (95% CI: 5.2 to 6.0). If all 
districts had received IRS, malaria risk in 2019 would have been 3.6 (95% CI: 3.1 to 4.1) and 4.3 
(95% CI: 3.7 to 4.8) in 2020. Had all districts received PBO-treated nets, risk would have been -
2.3% lower (95% CI: -2.7 to -1.9) in 2019 compared to 2018 high transmission seasons, and -
1.5% lower (95% CI: -2.0 to -1.0) in 2020 compared to 2018, relative to pyrethroid-treated nets. 
Had all districts had received IRS, risk would have been 1.4% lower (95% CI: -2.0 to -0.9) in 
2019 compared to 2018 high transmission seasons, and 2.8% lower (95% CI: -3.5 to -2.2) in 
2020 compared to 2018, relative to pyrethroid-treated nets. 
 The 2018 Malawi census recorded 17,563,749 million people;95 using our adjusted risk 
values we estimate that relative to national roll-out of pyrethroid-treated nets, distribution of 
PBO-treated nets in all districts in 2018 would have averted 665,522 (95% CI: 505,858 to 
825,185) confirmed cases and application of IRS would have averted 752,771 (95% CI: 532,559 
to 972,983) cases over the 2019 and 2020 high transmission seasons.  
 National average monthly temperature was similar in the months preceding 2018 and 
2019 high transmission seasons (Supplementary Figure B2). National average precipitation 
was slightly higher in the months preceding the 2019 high transmission season as compared to 
previous years, potentially influencing underlying malaria transmission.  
Discussion 
 Over 30 months, risk of malaria varied locally and was highest from January to May and 
among children <5 years of age. Malawi experienced declining national risk in 2019 and 
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subsequent rebound in 2020, however, patterns varied by district and intervention type. In 2020, 
12 of 28 districts (42.9%) experienced increases in malaria risk, suggesting that protective effects 
disappear 1 to 2 years after LLIN distribution. PBO-treated nets performed better than 
pyrethroid-treated nets in adjusted analyses. Annual IRS application sustained low malaria risk 
over two transmission seasons, and a single IRS application in 2019 reduced malaria risk in a 
district where pyrethroid-treated nets had no effect. Our findings suggest that national roll-out of 
PBO-treated LLINs or IRS would have the potential to avert hundreds of thousands of cases 
relative to pyrethroid-treated nets. Policy and programmatic prevention decisions have the 
potential to substantially alter Malawi’s malaria burden. 
 Longitudinal analysis demonstrates a reduction in malaria risk following mass LLIN 
distribution among our study population, but a subsequent re-bounding of disease suggests that 
LLINs do not universally retain effectiveness through two high transmission seasons. Prior 
research in Malawi has depicted increased malaria prevalence among children two years after 
mass distribution of 5.6 million nets, despite reporting increased bed net usage over the same 
time period.37 Individual ITN use was associated with a lower individual risk of malaria at 
baseline, but this association disappeared within two years. Similarly, research among 
adolescents and adults has shown that sleeping under an LLIN was not associated with reduced 
risk of malaria prevalence 3-4 years after a mass distribution campaign, even after stratifying by 
bed net insecticide type.38 
 Risk of malaria was heterogeneous at the health facility level, with wide variations 
depending on geographic location and month, aligning with estimated differences at the sub-
district level.50,51 Environmental risk factors contribute to fluctuations in malaria transmission, 
and elevation and rainfall55 are potential contributors to the spatial heterogeneity of LLIN effects 
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by district. Fine-scale longitudinal mapping of malaria risk allows for local monitoring and 
evaluation, including targeting of resources to small areas during periods of high transmission.  
 Potential sources of a short LLIN lifespan include repurposing, damage, and insecticide-
resistance, and attenuation of insecticide concentration. Mosquito collection studies in Malawi 
show increasing insecticide-resistance over time to pyrethroid-treated nets100, but retention of 
efficacy with added PBO, similar to our study findings. An estimated 50% of ITNs are lost from 
households in sub-Saharan Africa after 23 months, another likely contributor to reduced 
intervention effects over time.101 In Malawi, individuals repurpose ITNS for fishing and farming, 
and sell nets to support their families encountering poverty and food-insecurity,40 all of which 
contribute to reduced intervention effectiveness.   
 The frequency of LLIN distribution also influences effectiveness. The World Health 
Organization recommends mass distribution campaigns every 3 years, allocating one LLIN for 
every 1.8 people.80 However, evidence from field research in Eastern and Southern Africa 
questions this recommendation, consistently finding that malaria incidence rebounds 1-3 years 
following ITN or LLIN distribution.81–83,93,94 Qualitative studies are necessary to discover local 
reasons for LLIN effectiveness variation. Sites in Madagascar followed similar disease trends as 
our study, experiencing rebounding malaria 2-3 years following a mass distribution campaign; 
however, malaria incrementally declined in areas receiving additional continuous LLIN 
distribution to households including young children, immigrants, pregnancy women, and 
recently married couples.90 Malawi distributes nets continuously to pregnant women and 
newborns, but the protection provided by mass LLIN campaigns could be potentially sustained 
through introduction of additional distribution channels or expanded inclusion criteria. 
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 Our study represents one of the largest published analyses of LLIN effectiveness over 
time, capturing records from 711 health facilities over a 30-month period and representing the 
most granular national estimates published to-date. Data were reported at a near capacity rate 
each month, with 98% completeness in 2018 and 96% in 2019. Approximately 98% of all 
suspected cases were confirmed nationally in 2018, indicating high testing coverage of 
individuals presenting for care.32 Use of routinely collected DHIS2 data, provided by the 
National Malaria Control Programme, represents an efficient use of resources to study the 
effectiveness of Malawi’s most comprehensive malaria prevention intervention.  
 The main limitations of our analysis stem from missing data; we excluded facilities 
lacking spatial coordinates and missing 2018 data. However, many of the excluded health 
facilities were small, and our analysis still captured 97.1% (16.6 M/17.1 M) of confirmed DHIS2 
malaria cases and 99.7% (709/711) of facilities reported data for at least 24 months during the 
study period. We are also missing malaria cases who do not report to a clinic for diagnosis; a 
potentially substantial population as only 54% of children <5 years with fever sought advice or 
treatment in 2017.35 Our Thiessen polygons were built using Euclidean distance, assuming that 
individuals attend the nearest health facility and that everyone in the catchment area accesses the 
facility with equal probability. Facility size and quality of care also likely influences health 
seeking behavior, and referral hospitals may double count cases already recorded at smaller 
clinics. We updated projected WorldPop rasters using 2018 census data; while this provides 
more accurate population estimates, modeled population values are imperfect. We were not able 
to examine synergistic effects of IRS and LLINs, but future analysis will compare various 
intervention combinations as Malawi expands IRS coverage. Additional influences on malaria 
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counts include potential underreporting in April to June 2020 due to the COVID-19 pandemic, 
and introduction of limited RTS,S malaria vaccine roll-out to children in April 2019.  
 Our study design can serve as a model for other countries collecting health metrics 
through DHIS2. Use of a routine surveillance system provides a natural opportunity to study 
disease trends over time and create quasi-experimental designs to measure interventions on a 
large scale without the cost and limited scope of primary data collection. Assessment of malaria 
risk provides valuable insight into current and historical case trends as the Ministry of Health 
plans future mass distribution campaigns. Decisions regarding type of insecticide and frequency 
of net distribution have the potential to substantially alter the malaria landscape in Malawi, 




CHAPTER FIVE: DISCUSSION AND CONCLUSIONS 
Review of Aims 
 One of the goals of this manuscript was to understand the landscape of both 
asymptomatic and clinically confirmed malaria at fine geospatial scales. Aim 1 sought to identify 
which adolescents and adults are infected with asymptomatic P. falciparum infection, 
populations which are often omitted in malaria prevalence studies, but key to transmission in an 
endemic country. Through use of 2015-2016 MDHS dried blood spots collected from 
adolescents and adults ages 15-54 years, we conducted quantitative PCR to detect parasitemia. 
By linking PCR data with survey responses and other spatial and environmental data sources, we 
identified risk factors for infection including male sex, rurality, poverty, lower education, living 
in wetlands and grasslands, and higher environmental temperatures. Living in a household with a 
bed net (prevalence difference: 0.02, 95% CI: -0.02 to 0.05), living in a household with 1 net per 
1.8 household members (PD: 0.02; 95% CI: -0.01 to 0.06), and sleeping under an LLIN (PD: 
0.01; 95% CI: -0.02 to 0.04) were not protective against infection. When P. falciparum 
prevalence was mapped, cluster estimates ranged from 2.5% to 83.5% indicating high spatial 
heterogeneity. Prevalence estimates were much higher than modeled predictions and household 
survey measurements among children. Identifying risk factors for asymptomatic adult infection 
is essential for targeted interventions to high-risk sub-populations.  
 The goal of Aim 2 was to assess differences in the risk of clinically confirmed malaria at 
the health facility level before and after a mass LLIN distribution campaign. Using DHIS2 health 
facility surveillance data and WorldPop geospatial data, we compared risk in each month from 
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January 2018 to June 2020 among children <5 and persons ≥5 years. 711 health facilities 
contributed 20,962 facility reports. We created geospatial maps by high and low malaria 
transmission seasons to create the first visualizations of risk of malaria at the health facility level, 
enabling identification of high-risk areas and time periods. We stratified results by intervention 
type including PBO-treated nets, pyrethroid-treated nets, and/or application of IRS. Malaria risk 
decreased from 25.6 to 16.7 cases per 100 people from 2018 to 2019, and rebounded to 23.2 in 
2020, resulting in risk differences of -8·9 in 2019 and -2·4 in 2020 as compared to 2018. 
Piperonyl butoxide-treated (PBO) LLINs were more effective than pyrethroid-treated LLINs, 
with adjusted risk differences of -2.3 (95% CI: -2.7 to -1.9) cases per 100 people comparing 
2018 to 2019 and -1.5 (95% CI: -2·0 to -1·0) comparing 2018 to 2020. Relative to pyrethroid-
treated nets, national roll-out of PBO-treated nets in 2018 would have averted 665,522 (95% CI: 
505,858 to 825,185) confirmed cases of malaria over the 2019 and 2020 high transmission 
seasons following the mass campaign and national use of IRS would have averted 752,771 (95% 
CI: 532,559 to 972,983) cases. Findings suggest that while the World Health Organization 
recommends mass LLIN distribution every 3 years, the protective effects of LLINs disappear 1 
to 2 years after LLIN distribution in Malawi, leaving millions unprotected. Policy decisions 
regarding the type of LLIN used and application of IRS in national rollouts have the potential to 
substantially alter Malawi’s malaria burden, preventing morbidity, mortality, and a strain on 
health center resources for diagnosis and treatment. 
Conclusions 
 Answers to the research questions posed here contribute to filling gaps in knowledge 
about patterns of malaria risk in Malawi among adolescents and adults, at fine geospatial scales, 
and across months of the year. Use of molecular methods allowed a national molecular 
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assessment of malaria prevalence among adolescents and adults for the first time in Malawi, 
benefiting the MOH as the government prioritizes resources and interventions to high-risk areas 
and population groups. Malawi also benefits from analysis of DHIS2 data, which can become an 
ongoing surveillance tool to continuously monitor malaria risk and the benefits or lack of benefit 
contributed by roll-out of national or regional interventions against malaria. Use of MDHS 
samples and DHIS2 provides opportunities to use existing resources to answer additional 
research questions about malaria, without extra funds and manpower dedicated to primary data 
collection. Household surveys require extensive time and resources dedicated to active 
surveillance data collection efforts; the average cost of a DHS survey is $1.6 million and 
involves active visits to 27,516 individual households.46,53 Malawi spent an estimated $82 
million on malaria control in 201688 and malaria accounts for 30% of all outpatient visits and 
34% of inpatient hospital admissions.9 Households also often amass high direct and indirect costs 
due to clinical malarial disease, despite free diagnosis and treatment.89 Use of national existing 
surveillance data to inform policy makers can efficiently make use of both financial and human 
capital while reducing the malaria burden. 
 Malawi could benefit from more frequent mass distribution campaigns or additional 
expansion of annual IRS to a greater number of areas.9 Research from Madagascar shows that 
while LLIN mass distribution campaigns may only provide community protection for one year, 
protection can be sustained when campaigns are followed by continuous LLIN distribution to 
eligible households, including recently married couples, immigrants, children of vaccination age, 
and homes with uncovered sleeping areas.90 Malawi may also benefit from increased education 
on consistent and correct use of bed nets, and through expansion of continuous LLIN distribution 
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services to additional populations beyond pregnant women, targeting younger individuals living 
in rural areas with high prevalence of infection for more frequent net replacement.  
Future Directions 
 The enclosed findings represent a starting point for continued molecular and 
epidemiological malaria surveillance in Malawi. 2015-2016 MDHS dried blood spots can be 
further assessed for the presence of P. vivax, P. ovale, and P. malariae, species which are 
thought to be rare in sub-Saharan Africa, but which have never been measured nationally in 
Malawi using PCR-based methods. Instances of P. ovale and P. malariae have been identified 
among children using microscopy,35 but prevalence has not been assessed in adults, a large 
potential reservoir for transmission. Additionally, 2015-2016 MDHS dried blood spots can be 
subsequently tested for drug-resistant alleles, similar to what has been done in the Democratic 
Republic of the Congo.102 Similar molecular testing following the 2021 MDHS and future 
iterations of DHS among adults can be used to track changes in P. falciparum, other Plasmodium 
spp., and drug resistance alleles over time to determine the potential effectiveness of 
interventions. Collection of dried blood spots can also be added to MIS among children to better 
assess parasite prevalence and other genetic markers among all ages of the population. 
 As the RTS,S/AS01 malaria vaccine is programmatically tested in sub-Saharan Africa, 
molecular surveillance can also help monitor genetic changes in the population over time. 
RTS,S/AS01 has been shown to be more effective against malaria strains which match the 
vaccine construct as opposed to strains which mis-match,103 but researchers do not know the 
geographic prevalence of strain type across Malawi. 2015-2016 MDHS dried blood spots can be 
assessed for malaria strain prevalence, with analysis repeated after the 2021 MDHS to determine 
if introduction of the vaccine among children in 2019 causes specific strain-selection among 
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adults. Large-scale data collection across multiple years is necessary to track vaccine-induced 
variant selection on a population level. Antimalarial drug use creates known selective pressure 
towards drug resistance and other loci in Malawi,104 and within Africa and Asia,105 causing ebbs 
and flows of resistant strains with use and disuse of medications,106–108 and prompting 
hypotheses that similar selection could occur with the introduction of RTS,S/AS01. Genomics 
can be a useful tool to characterize parasite populations where malaria vaccines are more or less 
effective, monitor parasite populations where RTS,S/AS01 implementation has occurred, predict 
the effect of vaccine roll-outs in certain areas, and contribute to future vaccine development.109  
 DHIS2 can undergo frequent analysis, similar to the results provided here, to monitor 
clinically confirmed malaria risk among subpopulations and the effect of new interventions on 
disease risk over time. DHIS2 creates a sustainable feedback loop between health officials at the 
health facility, district, and national levels in Malawi, and the addition of regular analysis forms a 
partnership with research institutions to supplement MIS and DHS cross-sectional prevalence 
study results. Additional DHIS2 variables could be added to analysis to record aggregate case 
counts among school-aged children, and existing variables such as suspected malaria case counts 
and drug administration could be analyzed to determine geospatial and temporal differences in 
testing rates and drug stockouts.  
 To supplement results showing that LLINs in Malawi have a 1-2-year lifespan, future 
qualitative research can also be performed to identify local reasons for LLIN disuse. Along the 
shores of Lake Malawi, individuals have been found to repurpose ITNS for fishing and farming, 
and to sell nets to counter poverty and food-insecurity,40 but research is needed in other areas of 
the country to determine the best ways to extend LLIN lifespan or to better encourage LLIN use 
in households. Additionally, research questions can investigate different combinations of 
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interventions including variation in LLIN distribution, introduction of new LLIN types, 
expansion of continuous distribution to additional subpopulations, and co-application of LLINs 
and IRS within the same households. Cost-effectiveness studies can supplement program 
evaluation findings to create a more nuanced national strategy for malaria prevention.  
 Future replication of the analyses presented here will form a more complete longitudinal 
picture of asymptomatic infection and confirmed clinical disease in Malawi. Malawi’s Health 
Sector Strategic Plan aims to cut the malaria incidence rate of presumed and confirmed cases 
from 2015 levels of 380 per 1,000 to 200 per 1,000 by 2021.44 The same plan also hopes to cut 
inpatient malaria deaths per year from 23 per 100,000 to 14 per 100,000 within the same time 
period. Ongoing surveillance of disease and evaluation of prevention programs create 
opportunities to understand where to target interventions and which interventions to utilize to 
interrupt the transmission cycle most effectively. These and future data provide the MOH with 
valuable insight to avert malaria cases and save lives affected by a preventable disease.  
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APPENDIX A: CHAPTER THREE SUPPLEMENTARY MATERIALS 
Technical Methods 
DNA amplification and genotyping 
 DBS were punched in triplicate into 96 well plates using a 6 mm hole-punch at UNC 
Project-Malawi and shipped to the University of North Carolina at Chapel Hill for testing. DBS 
samples were stored at -20°C prior to parasite DNA extraction using a Tween-Chelex protocol 
modified from Teyssier et al. 2019. One milliliter of 0.5% Tween 20 in 1X PBS was added to 
each well and plates were incubated at room temperature overnight on shakers. After 
centrifuging, Tween-PBS was aspirated, and samples were washed with 1 mL of 1X PBS and 
underwent a 15-30-minute incubation at 4°C. After centrifuging again, PBS was aspirated and 
150 µL of a 1:2 solution of 20% Chelex 100 resin in water was added to each well and plates 
were incubated for 10 minutes at 95°C, occasionally shaking. Plates were centrifuged at 1,500 
rmp for 10 minutes and supernatant was transferred to non-skirted 96 well plates and centrifuged 
again at 1,500 rpm for 5 minutes, removing the supernatant to an Eppendorf LoBind DNA 96-
well plate for storage. DNA was extracted and stored at -80°C until qPCR.  
 Samples were run in singular in 384 well plates alongside 2 negative controls and 2 of 
each concentration of positive controls across a wide range of parasitemias: 100,000; 1,000; 100; 
10; and 1 parasite/µL. PCR primers and probe are noted in Supplementary Table A1. Real time 
PCR was conducted in 12 µL volumes, using Roche Universal Probe Master Mix and 2 µL of 
input DNA. The PCR cycles were 50C for 2 minutes and 95C for 10 minutes, followed by 40 
cycles of 95C denaturation for 15 seconds and 60C annealing/extension for 1 minute.  
Parasitemias were calculated using a trendline based on the Ct values of the positive control 
standards within each plate. 
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PCR assay validation 
 In total we conducted 908 control reactions, including 480 positive controls and 428 
negative controls (Supplementary Table A2). Negative controls were either water (n=48) or 
human DNA (0.1ng/µL) from a non-exposed population (n=380). Positive controls were 
generated across a range of parasitemias, from 10,000 parasites/µL  to 1 parasite/µL. Cultured 
parasites (strain 3D7, MRA-102, BEI Resources, Manassas VA) were quantified using repeated 
counts on a hemocytometer and mixed with human whole blood in order to mock desired 
parasitemias. The spiked blood was dried onto filter paper at 70 µL per spot, and DNA was 
extracted from these filter papers using the same methodology as the clinical samples. Extracted 
spiked blood DNA was used for all control reactions and would approximate any losses of DNA 
through the extraction process. We conducted a higher number of replicates at the lowest 
parasitemia value (n=194) to mimic the expected distribution of parasitemias in the clinical 
samples. All assay results and amplification curves were manually evaluated on the machine 
prior to exportation to the database. Based on these data, we estimated the sensitivity, specificity, 
negative predictive value (NPV) and positive predictive values (PPV) across a range of 
prevalence estimates (Supplementary Table A3). Samples amplified with a PCR cycle 
threshold (CT) value above 39 were considered negative in the final analysis to remain 
conservative in our classification of P. falciparum infected individuals. A 39-cycle cutoff is 
approximately one standard deviation above the mean Ct value for our 194 replicates of 1 
parasite/µl, our lowest positive control standard. The resultant data suggests that the assay has an 
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300 nM ACGATTTGGCTGGAGCAGAT 
Reverse 
primer 
300 nM TCTCTATTCCATTCTTTGTCACTCTTTC 
Probe 250 nM FAM-AGTAATAGTAACAGCTGGATTTACCAAGGCCCCA-TAMRA 
 
 
Supplementary Table A2 Control reactions. Negative controls represent water (n=48) or human 




at Ct 39 
% positive 
at Ct 39 




0 428 0 0 - - - 
1 194 148 76.3 37.5 37.1 1.61 
5 48 48 100 34.3 34.3 0.34 
10 84 83 98.8 33.7 33.4 1.12 
100 50 50 100 30.8 30.6 1.25 
1,000 52 52 100 26.5 26.3 0.89 





Supplementary Table A3 Sensitivity, specificity, negative predictive value, and positive 
predictive values across a range of P. falciparum prevalence estimates. 
 







- 90.2 100 - - 
0.1 - - 100 98.9 
0.2 - - 100 97.6 
0.3 - - 100 96.0 







Supplementary Table A4 Characteristics of 2015-16 MDHS samples which were available for 







n (%) n (%) 
Total 7732 7393   
# clusters 633 (74.5) 497 (58.5) 
 
Sex 
Male 3569 (46.2) 3472 (47.0) 0.3 
Female 4163 (53.8) 3921 (53.0)  
Age group (years) 
15-24 3257 (42.1) 3285 (44.4) 0.03 
25-34 2312 (29.9) 2093 (28.3)  
35-44 1554 (20.1) 1429 (19.3) 
 
45-54 609 (7.9) 586 (7.9)  
Wealth quintiles 
Poorest 1273 (16.5) 1100 (14.9) <0.001 
Poorer 1454 (18.8) 1338 (18.1)  
Middle 1536 (19.9) 1330 (18.0) 
 
Richer 1639 (21.2) 1471 (19.9)  
Richest 1830 (23.7) 2154 (29.1) 
 
Education 
None 610 (7.9) 548 (7.4) 0.001 
Primary 4701 (60.8) 4336 (58.7) 
 
Secondary 2129 (27.5) 2244 (30.4)  
Higher 
education 
277 (3.6) 238 (3.2) 
 
Missing 15 (0.2) 27 (0.4)  
Owns livestock, herds or farm 
animals 
No 3366 (43.5) 3354 (45.4) 0.02 
Yes 4366 (56.5) 4039 (54.6)  
Source of drinking water 
Piped 1772 (22.9) 2387 (32.3) <0.001 
Unpiped 5960 (77.1) 5006 (67.7)  
Household has a bed net 
No 2253 (29.1) 2299 (31.1) 0.009 
Yes 5479 (70.9) 5094 (68.9)  
Slept under an LLIN last 
night 
No 4957 (64.1) 4677 (63.3) 0.3 
Yes 2775 (35.9) 2716 (36.7)  
Insecticide of LLIN individual 
slept under last night 
Permethrin 1691 (60.9) 1641 (60.4) 0.6 
Non-
permethrin 
1084 (39.1) 1074 (39.5)  
Missing 0 (0.0) 1 (0.0) 
 
1 net per 1.8 household 
members 
No 7705 (99.7) 7357 (99.5) 0.4 





Anemia (women only) 
Not anemic 2770 (66.5) 2585 (65.9) 0.6 
Mild 1064 (25.6) 1027 (26.2) 
 
Moderate 296 (7.1) 283 (7.2)  
Severe 32 (0.8) 23 (0.6) 
 
Missing / NA 1 (0.0) 3 (0.1)  
Region 
Northern 1025 (13.3) 1896 (25.6) <0.001 
Central 3046 (39.4) 2357 (31.9)  
Southern 3661 (47.3) 3140 (42.5) 
 
Place of residence 
Urban 1541 (19.9) 1671 (22.6) <0.001 
Rural 6191 (80.1) 5722 (77.4) 
 
Elevation (m) 
<500 1480 (19.1) 1474 (19.9) <0.001 
≥ 500  & <1000 3190 (41.3) 2828 (38.3) 
 
≥ 1000 & 
<1500 
2891 (37.4) 2881 (39.0)  
≥ 1500 171 (2.2) 210 (2.8) 
 
Month of data collection 
October '15 1528 (19.8) 1038 (14.0) <0.001 
November '15 3070 (39.7) 2005 (27.1) 
 
December '15 1627 (21.0) 904 (12.2) 
 
January '16 1335 (17.3) 3078 (41.6) 
 
February '16 172 (2.2) 368 (5.0) 
 
Proportion of cluster with bed 
nets 
mean (SD) 0.68 (0.18) 0.68 (0.19) 0.5 
Proportion of cluster that 
slept under an LLIN last 
night 
mean (SD) 0.32 (0.16) 0.33 (0.15) <0.001 
* significance testing uses t-tests with an alpha=0.05 for continuous variables and chi-squared 






Supplementary Table A5 Bivariate associations between demographic and environmental risk 
factors and P. falciparum prevalence using weighted survey data. Samples amplified with a 














Male 0.303 - - - - 
Female 0.263 -0.04 -0.06 -0.01 0.002 
Age group (years) 
15-24 0.335 - - - - 
25-34 0.256 -0.08 -0.11 -0.05 <0.001 
35-44 0.227 -0.11 -0.15 -0.07 <0.001 
45-54 0.224 -0.11 -0.16 -0.06 <0.001 
Wealth quintiles 
Poorest 0.396 - - - - 
Poorer 0.351 -0.04 -0.09 0.00 0.04 
Middle 0.308 -0.09 -0.14 -0.04 <0.001 
Richer 0.239 -0.16 -0.20 -0.11 <0.001 
Richest 0.144 -0.25 -0.30 -0.20 <0.001 
Education 
None 0.305 - - - - 
Primary 0.322 0.02 -0.03 0.07 0.5 
Secondary 0.211 -0.09 -0.15 -0.04 0.001 
Higher 0.039 -0.27 -0.32 -0.21 <0.001 
Owns livestock, herds or farm 
animals      
No 0.270 - - - - 
Yes 0.292 0.02 -0.01 0.05 0.1 
Source of drinking water 
Piped 0.148 - - - - 
Unpiped 0.318 0.17 0.13 0.21 <0.001 
Household has a bed net 
No 0.283 - - - - 
Yes 0.281 0.00 -0.03 0.03 0.9 
Slept under an LLIN last night 
No 0.289 - - - - 
Yes 0.271 -0.02 -0.05 0.01 0.2 
Insecticide of LLIN individual 
slept under (out of individuals 
sleeping under nets) 
Permethrin 0.279 - - - - 
Non-
permethrin 
0.256 -0.02 -0.07 0.02 0.3 
At least 1 net per 1.8 household 
members 
No 0.230 - - - - 
Yes 0.295 0.07 0.02 0.11 0.002 
Anemia (women only) 
Not anemic 0.233 - - - - 
Mild 0.324 0.09 0.04 0.14 <0.001 
Moderate 0.317 0.08 0.01 0.16 0.03 




Northern 0.208 - - - - 
Central 0.318 0.11 0.06 0.16 <0.001 
Southern 0.279 0.07 0.02 0.12 0.006 
Place of residence 
Urban 0.112 - - - - 
Rural 0.314 0.2 0.16 0.24 <0.001 
Elevation (m) 
<500 0.266 - - - - 
≥ 500  & 
<1000 
0.347 0.08 0.02 0.14 0.01 
≥ 1000 & 
<1500 
0.244 -0.02 -0.08 0.04 0.5 
≥ 1500 0.096 -0.17 -0.23 -0.11 <0.001 
Month of data collection 
October '15 0.394 - - - - 
November '15 0.255 -0.14 -0.21 -0.07 <0.001 
December '15 0.220 -0.17 -0.26 -0.09 <0.001 
January '16 0.250 -0.14 -0.21 -0.08 <0.001 
February '16 0.349 -0.04 -0.16 0.07 0.4 
Landcover 
Settlement 0.096 - - - - 
Forest 0.314 0.22 0.15 0.29 <0.001 
Grassland 0.322 0.23 0.13 0.32 <0.001 
Cropland 0.310 0.21 0.18 0.25 <0.001 
Wetland 0.354 0.26 0.16 0.36 <0.001 
Other 0.107 0.01 -0.02 0.04 0.5 
Proportion of cluster with bed 
nets (scaled) 
Mean 0.282 - - - - 
10% increase - -0.05 -0.17 0.08 0.5 
Proportion of cluster that slept 
under an LLIN last night (scaled) 
Mean 0.282 - - - - 
10% increase - -0.11 -0.25 0.03 0.1 
Current month's average daily 
maximum temperature (°C) 
(scaled) 
Mean 0.282 - - - - 
1°C increase - 0.02 0.01 0.03 <0.001 
Prior month's precipitation (mm) 
(scaled) 
Mean 0.282 - - - - 
100 mm 
increase 
- -0.02 -0.04 0.01 0.2 








Supplementary Table A6 Bivariate associations between demographic and environmental risk 
factors and P. falciparum prevalence using weighted survey data. Samples amplified with a 














Male 0.266 - - - - 
Female 0.229 -0.04 -0.06 -0.01 0.003 
Age group (years) 
15-24 0.296 - - - - 
25-34 0.226 -0.07 -0.1 -0.04 <0.001 
35-44 0.198 -0.10 -0.14 -0.06 <0.001 
45-54 0.171 -0.13 -0.17 -0.08 <0.001 
Wealth quintiles 
Poorest 0.352 - - - - 
Poorer 0.314 -0.04 -0.08 0.00 0.08 
Middle 0.272 -0.08 -0.13 -0.03 0.001 
Richer 0.204 -0.15 -0.19 -0.11 <0.001 
Richest 0.117 -0.24 -0.28 -0.19 <0.001 
Education 
None 0.258 - - - - 
Primary 0.286 0.03 -0.02 0.07 0.2 
Secondary 0.175 -0.08 -0.14 -0.03 0.002 
Higher 0.039 -0.22 -0.27 -0.16 <0.001 
Owns livestock, herds or farm 
animals      
No 0.234 - - - - 
Yes 0.257 0.02 0.00 0.05 0.1 
Source of drinking water 
Piped 0.120 - - - - 
Unpiped 0.280 0.16 0.13 0.19 <0.001 
Household has a bed net 
No 0.247 - - - - 
Yes 0.246 0.00 -0.03 0.03 0.9 
Slept under an LLIN last night 
No 0.256 - - - - 
Yes 0.231 -0.02 -0.05 0.00 0.1 
Insecticide of LLIN individual 
slept under (out of individuals 
sleeping under nets) 
Permethrin 0.237 - - - - 
Non-
permethrin 
0.220 -0.02 -0.06 0.03 0.5 
At least 1 net per 1.8 household 
members 
No 0.193 - - - - 
Yes 0.260 0.07 0.03 0.11 0.001 
Anemia (women only) 
Not anemic 0.201 - - - - 
Mild 0.285 0.08 0.04 0.13 <0.001 
Moderate 0.279 0.08 0.01 0.15 0.04 




Northern 0.188 - - - - 
Central 0.278 0.09 0.04 0.14 <0.001 
Southern 0.241 0.05 0.01 0.10 0.02 
Place of residence 
Urban 0.082 - - - - 
Rural 0.277 0.19 0.16 0.22 <0.001 
Elevation (m) 
<500 0.238 - - - - 
≥ 500  & 
<1000 
0.306 0.07 0.01 0.13 0.02 
≥ 1000 & 
<1500 
0.210 -0.03 -0.08 0.02 0.3 
≥ 1500 0.073 -0.17 -0.22 -0.11 <0.001 
Month of data collection 
October '15 0.343 - - - - 
November '15 0.226 -0.12 -0.19 -0.05 0.001 
December '15 0.194 -0.15 -0.23 -0.07 <0.001 
January '16 0.216 -0.13 -0.19 -0.06 <0.001 
February '16 0.306 -0.04 -0.14 0.07 0.5 
Landcover 
Settlement 0.074 - - - - 
Forest 0.273 0.20 0.14 0.26 <0.001 
Grassland 0.274 0.20 0.11 0.28 <0.001 
Cropland 0.276 0.20 0.17 0.23 <0.001 
Wetland 0.301 0.23 0.14 0.32 <0.001 
Other 0.062 -0.01 -0.05 0.02 0.5 
Proportion of cluster with bed 
nets (scaled) 
Mean 0.247 - - - - 
10% increase - -0.05 -0.17 0.06 0.4 
Proportion of cluster that slept 
under an LLIN last night (scaled) 
Mean 0.247 - - - - 
10% increase - -0.13 -0.25 0.00 0.06 
Current month's average daily 
maximum temperature (°C) 
(scaled) 
Mean 0.246 - - - - 
1°C increase - 0.02 0.01 0.03 <0.001 
Prior month's precipitation (mm) 
(scaled) 
Mean 0.247 - - - - 
100 mm 
increase 
- -0.01 -0.04 0.01 0.3 




Supplementary Table A7 Multivariate associations between bed net associated risk factors and 
P. falciparum prevalence using weighted survey data. Samples amplified with a qPCR cycle 








Household has a bed net 
Unadjusted 0.00 -0.03 0.03 0.9 
Adjusted* 0.02 -0.01 0.06 0.2 
Slept under an LLIN last night 
Unadjusted -0.02 -0.05 0.01 0.2 
Adjusted* 0.01 -0.02 0.04 0.6 
Individual slept under LLIN treated 
with non-permethrin (vs. permethrin) 
Unadjusted -0.02 -0.07 0.02 0.3 
Adjusted† -0.02 -0.06 0.02 0.4 
At least 1 net per 1.8 household 
members 
Unadjusted 0.07 0.02 0.11 0.002 
Adjusted§ 0.01 -0.03 0.04 0.8 
* models adjusted for age, sex, wealth, and household size 
† model adjusted for age, sex, and wealth 
§ model adjusted for wealth and district  
Note: LLIN = long-lasting insecticide treated net 
 
 
Supplementary Table A8 Multivariate associations between bed net associated risk factors and 
P. falciparum prevalence using weighted survey data. Samples amplified with a qPCR cycle 








Household has a bed net 
Unadjusted 0.00 -0.03 0.03 0.9 
Adjusted* 0.00 -0.03 0.03 1.0 
Slept under an LLIN last night 
Unadjusted -0.02 -0.05 0.00 0.1 
Adjusted† 0.00 -0.02 0.03 0.9 
Individual slept under LLIN treated 
with non-permethrin (vs. permethrin) 
Unadjusted -0.02 -0.06 0.03 0.5 
Adjusted† -0.01 -0.05 0.03 0.7 
At least 1 net per 1.8 household 
members 
Unadjusted 0.07 0.03 0.11 0.001 
Adjusted§ 0.01 -0.01 0.04 0.3 
* models adjusted for age and sex 
† model adjusted for age, sex, and wealth 
§ model adjusted for wealth and district  




Supplementary Table A9 P. falciparum prevalence stratified by month and region. 
 









Northern 278 9.0 0.291 
Central 1094 35.5 0.282 
Southern 1706 55.4 0.264 
February 
Northern 213 57.9 0.268 
Central 137 37.2 0.467 
Southern 18 4.9 0.444 
October 
Northern 65 6.3 0.246 
Central 454 43.7 0.377 
Southern 519 50.0 0.428 
November 
Northern 824 41.1 0.223 
Central 486 24.2 0.358 
Southern 695 34.7 0.273 
December 
Northern 516 57.1 0.188 
Central 186 20.6 0.285 




Supplementary Figure A1 Weighted P. falciparum prevalence at various CT values (n=7,393). 
The q-PCR cycle number shows how many cycles occurred before the sample’s reaction curve 
crossed the threshold for a positive result.  
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APPENDIX B: CHAPTER FOUR SPPLEMENTARY MATERIALS 
 
Supplementary Table B1 Proportion of health facilities, health facility reports, and confirmed 
malaria cases included in the study analysis and in DHIS2, by year.  




DHIS2 %   
included 
in study 






711 756 94.0   8,170 8,607 94.9   6,833,895 6,997,921 97.7 
2019:  
Jan-Dec 
711 925 76.9   8,526 10,992 77.6   5,074,442 5,229,573 97.0 
2020:  
Jan-Jun 
711 926 76.8   4,266 5,500 77.6   4,664,899 4,839,038 96.4 
TOTAL 711 926 76.8   20,962 25,099 83.5   16,573,236 17,066,532 97.1 










Supplementary Table B2 Bed net coverage by district, calculated using 2018 Malawi census 
population counts and bed net distribution counts for all health facilities included in the analysis 
(n=711). Nkhotakota did not distribute bed nets, but sprayed 112,264 structures in 2018, 















Balaka Pyrethroid 448,706 301,033 67.1 1.5 
Blantyre Pyrethroid 1,251,484 692,646 55.3 1.8 
Chikwawa Pyrethroid 534,779 396,272 74.1 1.3 
Chiradzulu Pyrethroid 356,875 238,011 66.7 1.5 
Chitipa Pyrethroid 234,927 129,579 55.2 1.8 
Dedza Pyrethroid 830,512 518,538 62.4 1.6 
Dowa Pyrethroid 772,569 461,366 59.7 1.7 
Karonga PBO 365,028 253,486 69.4 1.4 
Kasungu Pyrethroid 842,953 513,735 60.9 1.6 
Likoma PBO 14,527 8,535 58.8 1.7 
Lilongwe Pyrethroid 2,626,901 1,441,780 54.9 1.8 
Machinga PBO 735,438 518,742 70.5 1.4 
Mangochi Pyrethroid / IRS 1,148,611 784,210 68.3 1.5 
Mchinji Pyrethroid / PBO 602,305 413,605 68.7 1.5 
Mulanje Pyrethroid 684,107 466,162 68.1 1.5 
Mwanza PBO 130,949 84,698 64.7 1.5 
Mzimba Pyrethroid 1,161,456 672,652 57.9 1.7 
Neno PBO 167,409 81,198 48.5 2.1 
Nkhata Bay Pyrethroid 284,681 179,657 63.1 1.6 
Nkhotakota IRS 393,077 .. .. .. 
Nsanje PBO 503,412 230,374 45.8 2.2 
Ntcheu Pyrethroid 659,608 392,781 59.5 1.7 
Ntchisi PBO 317,069 190,242 60.0 1.7 
Phalombe Pyrethroid 398,666 285,977 71.7 1.4 
Rumphi PBO 229,161 140,902 61.5 1.6 
Salima PBO 478,346 327,771 68.5 1.5 
Thyolo Pyrethroid 721,456 481,419 66.7 1.5 
Zomba Pyrethroid 860,604 583,576 67.8 1.5 
TOTAL .. 17,755,616 10,788,947 68.8 1.6 




Supplementary Table B3 Risk of malaria (cases per 100 people) by month from January 2018 
to June 2020, stratified by age group and intervention type. ‘No data’ refers to health facilities 


















18-Jan 14.9 3.4 5.0   10.8 5.0 6.1 4.5 1.4 
18-Feb 13.5 3.0 4.5   8.0 4.7 5.0 3.8 1.2 
18-Mar 16.5 3.5 5.4   8.3 5.6 6.0 4.8 1.7 
18-Apr 16.4 3.8 5.7   9.8 6.0 6.0 4.8 1.9 
18-May 15.6 3.4 5.2   9.2 5.4 5.5 5.0 1.8 
18-Jun 9.7 2.2 3.3   6.2 3.2 4.3 2.7 1.3 
18-Jul 7.6 1.4 2.3   7.9 2.3 3.0 2.5 0.5 
18-Aug 6.2 1.1 1.8   7.6 1.7 2.7 2.0 0.4 
18-Sep 6.7 1.2 2.0   8.2 1.7 2.9 2.6 0.4 
18-Oct 6.8 1.3 2.1   8.8 2.0 2.9 2.1 0.4 
18-Nov 5.5 1.0 1.7   4.6 1.7 2.1 1.5 0.4 
18-Dec 5.8 1.0 1.7   2.4 1.9 1.9 1.5 0.4 
19-Jan 9.7 2.4 3.5   3.3 3.9 3.4 4.5 0.8 
19-Feb 8.5 2.1 3.0   3.0 3.5 2.3 4.0 0.9 
19-Mar 9.2 2.4 3.4   3.3 4.3 1.9 3.5 0.9 
19-Apr 9.4 2.3 3.3   3.6 4.2 1.8 3.7 0.9 
19-May 9.6 2.5 3.5   3.9 4.5 1.8 3.9 0.9 
19-Jun 6.4 1.3 2.1   4.2 2.5 1.2 2.5 0.6 
19-Jul 5.6 1.0 1.6   4.5 1.9 1.1 2.4 0.5 
19-Aug 4.8 0.8 1.4   5.4 1.4 1.1 2.4 0.4 
19-Sep 5.0 0.9 1.5   6.1 1.5 1.4 2.2 0.4 
19-Oct 5.7 1.1 1.7   7.1 1.7 1.5 2.8 0.5 
19-Nov 5.0 1.1 1.6   5.1 1.8 1.4 1.9 0.5 
19-Dec 5.9 1.3 2.0   1.9 2.3 2.0 1.5 0.6 
20-Jan 12.9 3.6 5.0   3.9 6.1 5.0 1.7 1.4 
20-Feb 10.6 3.0 4.1   3.4 5.1 3.8 1.3 1.1 
20-Mar 13.1 4.1 5.4   4.6 6.8 4.8 1.8 1.4 
20-Apr 11.8 3.4 4.6   3.8 5.7 4.5 1.7 1.3 
20-May 11.3 2.9 4.1   4.3 5.0 4.3 1.7 1.1 
20-Jun 9.1 2.0 3.0   4.1 3.5 3.4 1.5 0.8 




Supplementary Figure B1 Risk of malaria from January 2018 to June 2020, stratified by 
district, all ages. Line colors represent the type of invention which households in each district 
received Dark gray color blocks represent months where the mass distribution campaign 
occurred (September to December 2018) and light gray blocks represent months which fall 
during the yearly high malaria transmission season (January to May). Risk was measured 
monthly and curves are smoothed using X-splines. Note: IRS = indoor residual spraying, PBO = 





































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Supplementary Figure B2 A) average monthly temperature and B) total monthly precipitation, 
Malawi, 2000 to 2019. Stars indicate peaks in November and December 2018, respectively, 
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